QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
(Address of principal executive offices) |
(Zip Code) |
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer |
☐ | Smaller reporting company | ||||
Emerging growth company |
Title of Each Class |
Trading Symbol |
Name of each exchange on which registered | ||
value $.001 per share |
September 30, 2021 |
December 31, 2020 |
|||||||
Assets |
||||||||
Investments: |
||||||||
Fixed maturity securities available-for-sale, |
$ | $ | ||||||
Equity securities, at fair value |
||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $ |
||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Commercial mortgage loans, net |
||||||||
Policy loans |
||||||||
Other invested assets |
||||||||
|
|
|
|
|||||
Total investments |
||||||||
Cash, cash equivalents and restricted cash |
||||||||
Accrued investment income |
||||||||
Deferred acquisition costs |
||||||||
Intangible assets |
||||||||
Reinsurance recoverable |
||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Reinsurance recoverable, net |
||||||||
Other assets |
||||||||
Deferred tax asset |
||||||||
Separate account assets |
||||||||
Assets related to discontinued operations |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities and equity |
||||||||
Liabilities: |
||||||||
Future policy benefits |
$ | $ | ||||||
Policyholder account balances |
||||||||
Liability for policy and contract claims |
||||||||
Unearned premiums |
||||||||
Other liabilities |
||||||||
Long-term borrowings |
||||||||
Separate account liabilities |
||||||||
Liabilities related to discontinued operations |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies |
||||||||
Equity: |
||||||||
Class A common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive income (loss) |
||||||||
Retained earnings |
||||||||
Treasury stock, at cost ( |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Genworth Financial, Inc.’s stockholders’ equity |
||||||||
Noncontrolling interests |
||||||||
|
|
|
|
|||||
Total equity |
||||||||
|
|
|
|
|||||
Total liabilities and equity |
$ | $ | ||||||
|
|
|
|
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | $ | $ | $ | ||||||||||||
Net investment income |
||||||||||||||||
Net investment gains (losses) |
||||||||||||||||
Policy fees and other income |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenues |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
||||||||||||||||
Interest credited |
||||||||||||||||
Acquisition and operating expenses, net of deferrals |
||||||||||||||||
Amortization of deferred acquisition costs and intangibles |
||||||||||||||||
Interest expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total benefits and expenses |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from continuing operations before income taxes |
||||||||||||||||
Provision for income taxes |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from continuing operations |
||||||||||||||||
Income (loss) from discontinued operations, net of taxes |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
( |
) | ||||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ||||||||||||
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
Basic |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
Basic |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted-average common shares outstanding: |
||||||||||||||||
Basic |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
||||||||||||||||
|
|
|
|
|
|
|
|
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Net income (loss) |
$ | $ | $ | $ | ( |
) | ||||||||||
Other comprehensive income (loss), net of taxes: |
||||||||||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
( |
) | ( |
) | ||||||||||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
( |
) | ( |
) | ||||||||||||
Derivatives qualifying as hedges |
( |
) | ( |
) | ( |
) | ||||||||||
Foreign currency translation and other adjustments |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other comprehensive income (loss) |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive income |
||||||||||||||||
Less: comprehensive income attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
Three months ended September 30, 2021 |
||||||||||||||||||||||||||||||||
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Retained earnings |
Treasury stock, at cost |
Total Genworth Financial, Inc.’s stockholders’ equity |
Noncontrolling interests |
Total equity |
|||||||||||||||||||||||||
Balances as of June 30, 2021 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Initial sale of subsidiary shares to noncontrolling interests |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||
Other comprehensive loss, net of taxes |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total comprehensive income |
||||||||||||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balances as of September 30, 2021 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, 2020 |
||||||||||||||||||||||||||||||||
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Retained earnings |
Treasury stock, at cost |
Total Genworth Financial, Inc.’s stockholders’ equity |
Noncontrolling interests |
Total equity |
|||||||||||||||||||||||||
Balances as of June 30, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of taxes |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total comprehensive income |
||||||||||||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balances as of September 30, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, 2021 |
||||||||||||||||||||||||||||||||
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Retained earnings |
Treasury stock, at cost |
Total Genworth Financial, Inc.’s stockholders’ equity |
Noncontrolling interests |
Total equity |
|||||||||||||||||||||||||
Balances as of December 31, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Initial sale of subsidiary shares to noncontrolling interests |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Sale of business that included noncontrolling interests |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of taxes |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total comprehensive income |
||||||||||||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balances as of September 30, 2021 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, 2020 |
||||||||||||||||||||||||||||||||
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Retained earnings |
Treasury stock, at cost |
Total Genworth Financial, Inc.’s stockholders’ equity |
Noncontrolling interests |
Total equity |
|||||||||||||||||||||||||
Balances as of December 31, 2019 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Cumulative effect of change in accounting, net of taxes |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net income (loss) |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Other comprehensive income, net of taxes |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total comprehensive income |
||||||||||||||||||||||||||||||||
Dividends to noncontrolling interests |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balances as of September 30, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, |
||||||||
2021 |
2020 |
|||||||
Cash flows from operating activities: |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Less (income) loss from discontinued operations, net of taxes |
( |
) | ||||||
Adjustments to reconcile net income (loss) to net cash from operating activities: |
||||||||
Amortization of fixed maturity securities discounts and premiums |
( |
) | ( |
) | ||||
Net investment gains |
( |
) | ( |
) | ||||
Charges assessed to policyholders |
( |
) | ( |
) | ||||
Acquisition costs deferred |
( |
) | ||||||
Amortization of deferred acquisition costs and intangibles |
||||||||
Deferred income taxes |
||||||||
Derivative instruments, limited partnerships and other |
( |
) | ||||||
Stock-based compensation expense |
||||||||
Change in certain assets and liabilities: |
||||||||
Accrued investment income and other assets |
( |
) | ( |
) | ||||
Insurance reserves |
||||||||
Current tax liabilities |
( |
) | ||||||
Other liabilities, policy and contract claims and other policy-related balances |
||||||||
Cash used by operating activities—discontinued operations |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net cash from operating activities |
||||||||
|
|
|
|
|||||
Cash flows from (used by) investing activities: |
||||||||
Proceeds from maturities and repayments of investments: |
||||||||
Fixed maturity securities |
||||||||
Commercial mortgage loans |
||||||||
Other invested assets |
||||||||
Proceeds from sales of investments: |
||||||||
Fixed maturity and equity securities |
||||||||
Purchases and originations of investments: |
||||||||
Fixed maturity and equity securities |
( |
) | ( |
) | ||||
Commercial mortgage loans |
( |
) | ( |
) | ||||
Other invested assets |
( |
) | ( |
) | ||||
Short-term investments, net |
( |
) | ||||||
Policy loans, net |
||||||||
Proceeds from sale of business, net of cash transferred |
||||||||
Cash used by investing activities—discontinued operations |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net cash from (used by) investing activities |
( |
) | ||||||
|
|
|
|
|||||
Cash flows used by financing activities: |
||||||||
Deposits to universal life and investment contracts |
||||||||
Withdrawals from universal life and investment contracts |
( |
) | ( |
) | ||||
Redemption of non-recourse funding obligations |
( |
) | ||||||
Proceeds from issuance of long-term debt |
||||||||
Repayment and repurchase of long-term debt |
( |
) | ( |
) | ||||
Proceeds from sale of subsidiary shares to noncontrolling interests |
||||||||
Other, net |
||||||||
Cash from financing activities—discontinued operations |
||||||||
|
|
|
|
|||||
Net cash used by financing activities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $( |
||||||||
|
|
|
|
|||||
Net change in cash, cash equivalents and restricted cash |
( |
) | ( |
) | ||||
Cash, cash equivalents and restricted cash at beginning of period |
||||||||
|
|
|
|
|||||
Cash, cash equivalents and restricted cash at end of period |
||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
||||||||
|
|
|
|
|||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | $ | ||||||
|
|
|
|
• | Enact (formerly known as U.S. Mortgage Insurance). |
• | U.S. Life Insurance. |
• | Runoff. |
• | In July 2021, Genworth Holdings early redeemed its |
• | As part of the settlement agreement reached in July 2020 regarding the case titled AXA S.A. v. Genworth Financial International Holdings, LLC et al., |
• | Genworth Holdings received intercompany cash tax payments from its subsidiaries during the nine months ended September 30, 2021 generated from taxable income. Additional intercompany cash tax payments are expected in future periods. |
• | assumptions will no longer be locked-in at contract inception and all cash flow assumptions used to estimate the liability for future policy benefits (except the discount rate) will be reviewed at least annually in the same period each year or more frequently if actual experience indicates a change is required. Changes will be recorded in net income (loss) using a retrospective approach with a cumulative catch-up adjustment by recalculating the net premium ratio (which will be capped at 100%) using actual historical and updated future cash flow assumptions; |
• | the discount rate used to determine the liability for future policy benefits will be a current upper-medium grade (low credit risk) fixed-income instrument yield, which is generally interpreted to mean a single-A rated bond rate for the same duration, and is required to be reviewed quarterly, with changes in the discount rate recorded in other comprehensive income (loss); |
• | the provision for adverse deviation and the premium deficiency test will be eliminated; |
• | market risk benefits associated with deposit-type contracts will be measured at fair value with changes related to instrument-specific credit risk recorded in other comprehensive income (loss) and remaining changes recorded in net income (loss); |
• | the amortization method for DAC will generally be on a straight-line basis over the expected contract term; and |
• | disclosures will be greatly expanded to include significant assumptions and product liability rollforwards. |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions, except per share amounts) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Weighted-average shares used in basic earnings per share calculations |
||||||||||||||||
Potentially dilutive securities: |
||||||||||||||||
Stock options, restricted stock units and stock appreciation rights |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted-average shares used in diluted earnings per share calculations |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from continuing operations: |
||||||||||||||||
Income from continuing operations |
$ | $ | $ | $ | ||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic per share |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted per share |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) from discontinued operations: |
||||||||||||||||
Income (loss) from discontinued operations, net of taxes |
$ | $ | $ | $ | ( |
) | ||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic per share |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted per share |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss): |
||||||||||||||||
Income from continuing operations |
$ | $ | $ | $ | ||||||||||||
Income (loss) from discontinued operations, net of taxes |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
( |
) | ||||||||||||||
Less: net income attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic per share (1) |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted per share |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
(1) |
May not total due to whole number calculation. |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Fixed maturity securities—taxable |
$ | $ | $ | $ | ||||||||||||
Fixed maturity securities—non-taxable |
||||||||||||||||
Equity securities |
||||||||||||||||
Commercial mortgage loans |
||||||||||||||||
Policy loans |
||||||||||||||||
Other invested assets |
||||||||||||||||
Cash, cash equivalents, restricted cash and short-term investments |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross investment income before expenses and fees |
||||||||||||||||
Expenses and fees |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Available-for-sale |
||||||||||||||||
Realized gains |
$ | $ | $ | $ | ||||||||||||
Realized losses |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net realized gains (losses) on available-for-sale |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net change in allowance for credit losses on available-for-sale |
( |
) | ( |
) | ||||||||||||
Write-down of available-for-sale (1) |
( |
) | ( |
) | ( |
) | ||||||||||
Net realized gains (losses) on equity securities sold |
( |
) | ( |
) | ( |
) | ||||||||||
Net unrealized gains (losses) on equity securities still held |
( |
) | ( |
) | ( |
) | ||||||||||
Limited partnerships |
||||||||||||||||
Commercial mortgage loans |
( |
) | ( |
) | ||||||||||||
Derivative instruments (2) |
( |
) | ( |
) | ||||||||||||
Other |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment gains (losses) |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(1) |
Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis. |
(2) |
See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). |
(Amounts in millions) |
Beginning balance |
Increase from securities without allowance in previous periods |
Increase (decrease) from securities with allowance in previous periods |
Securities sold |
Decrease due to change in intent or requirement to sell |
Write-offs |
Recoveries |
Ending balance |
||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||
Non-U.S. corporate |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total available-for-sale maturity securities |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Beginning balance |
Increase from securities without allowance in previous periods |
Increase (decrease) from securities with allowance in previous periods |
Securities sold |
Decrease due to change in intent or requirement to sell |
Write-offs |
Recoveries |
Ending balance |
||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||
Non-U.S. corporate |
$ | $ | $ | ( |
) | $ | $ | $ | $ | $ | ||||||||||||||||||||||
Commercial mortgage - b acked |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total available-for-sale maturity securities |
$ | $ | $ | ( |
) | $ | $ | $ | $ | $ | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Beginning balance |
Increase from securities without allowance in previous periods |
Increase (decrease) from securities with allowance in previous periods |
Securities sold |
Decrease due to change in intent or requirement to sell |
Write-offs |
Recoveries |
Ending balance |
||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||
Non-U.S. corporate |
$ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ||||||||||||||||||||||
Commercial mortgage - backed |
( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total available-for-sale |
$ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Beginning balance |
Increase from securities without allowance in previous periods |
Increase (decrease) from securities with allowance in previous periods |
Securities sold |
Decrease due to change in intent or requirement to sell |
Write-offs |
Recoveries |
Ending balance |
||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||
Non-U.S. corporate |
$ | $ | $ | ( |
) | $ | $ | $ | $ | $ | ||||||||||||||||||||||
Commercial mortgage - backed |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total available-for-sale maturity securities |
$ | $ | $ | ( |
) | $ | $ | $ | $ | $ | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
September 30, 2021 |
December 31, 2020 |
||||||
Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses (1) |
$ | $ | ||||||
Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses (1) |
( |
) | ||||||
Adjustments to DAC, present value of future profits, sales inducements, benefit reserves and policyholder contract balances |
( |
) | ( |
) | ||||
Income taxes, net |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net unrealized investment gains (losses) |
||||||||
Less: net unrealized investment gains (losses) attributable to noncontrolling interests |
||||||||
|
|
|
|
|||||
Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. |
$ | $ | ||||||
|
|
|
|
(1) |
Excludes foreign exchange. |
As of or for the three months ended September 30, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Beginning balance |
$ | $ | ||||||
Unrealized gains (losses) arising during the period: |
||||||||
Unrealized gains (losses) on fixed maturity securities |
( |
) | ||||||
Adjustment to deferred acquisition costs |
( |
) | ||||||
Adjustment to present value of future profits |
( |
) | ||||||
Adjustment to sales inducements |
( |
) | ||||||
Adjustment to benefit reserves |
( |
) | ||||||
Provision for income taxes |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Change in unrealized gains (losses) on investment securities |
||||||||
Reclassification adjustments to net investment (gains) losses, net of taxes of $ |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Change in net unrealized investment gains (losses) |
( |
) | ||||||
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests |
||||||||
|
|
|
|
|||||
Ending balance |
$ | $ | ||||||
|
|
|
|
As of or for the nine months ended September 30, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Beginning balance |
$ | $ | ||||||
Unrealized gains (losses) arising during the period: |
||||||||
Unrealized gains (losses) on fixed maturity securities |
( |
) | ||||||
Adjustment to deferred acquisition costs |
( |
) | ||||||
Adjustment to present value of future profits |
||||||||
Adjustment to sales inducements |
( |
) | ||||||
Adjustment to benefit reserves |
( |
) | ||||||
Provision for income taxes |
( |
) | ||||||
|
|
|
|
|||||
Change in unrealized gains (losses) on investment securities |
( |
) | ||||||
Reclassification adjustments to net investment (gains) losses, net of taxes of $ |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Change in net unrealized investment gains (losses) |
( |
) | ||||||
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests |
( |
) | ||||||
|
|
|
|
|||||
Ending balance |
$ | $ | ||||||
|
|
|
|
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
State and political subdivisions |
( |
) | ||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total U.S. corporate |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total non-U.S. corporate |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||
Other asset-backed |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total available-for-sale |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
State and political subdivisions |
( |
) | ||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total U.S. corporate |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Residential mortgage-backed |
||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ||||||||||||||||
Other asset-backed |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total available-for-sale |
$ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||
|
|
|
|
|
|
|
|
|
|
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
U.S. government, agencies and - sponsored enterprises |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
State and political subdivisions |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
% Below cost: |
||||||||||||||||||||||||||||||||||||
<20% Below cost |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
20%-50% Below cost |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Investment grade |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Below investment grade |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Subtotal, U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Subtotal, non-U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total for corporate securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
% Below cost: |
||||||||||||||||||||||||||||||||||||
<20% Below cost |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
20%-50% Below cost |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Investment grade |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Below investment grade |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Subtotal, U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Subtotal, non-U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total for corporate securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Amortized cost or cost |
Fair value |
||||||
Due one year or less |
$ | $ | ||||||
Due after one year through five years |
||||||||
Due after five years through ten years |
||||||||
Due after ten years |
||||||||
|
|
|
|
|||||
Subtotal |
||||||||
Residential mortgage-backed |
||||||||
Commercial mortgage-backed |
||||||||
Other asset-backed |
||||||||
|
|
|
|
|||||
Total |
$ | $ | ||||||
|
|
|
|
September 30, 2021 |
December 31, 2020 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Property type: |
||||||||||||||||
Retail |
$ | % | $ | % | ||||||||||||
Industrial |
||||||||||||||||
Office |
||||||||||||||||
Apartments |
||||||||||||||||
Mixed use |
||||||||||||||||
Other |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Subtotal |
% | % | ||||||||||||||
|
|
|
|
|||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|||||||||||||
Total |
$ | $ | ||||||||||||||
|
|
|
|
September 30, 2021 |
December 31, 2020 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Geographic region: |
||||||||||||||||
South Atlantic |
$ | % | $ | % | ||||||||||||
Pacific |
||||||||||||||||
Middle Atlantic |
||||||||||||||||
Mountain |
||||||||||||||||
West North Central |
||||||||||||||||
West South Central |
||||||||||||||||
East North Central |
||||||||||||||||
New England |
||||||||||||||||
East South Central |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Subtotal |
% | % | ||||||||||||||
|
|
|
|
|||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|||||||||||||
Total |
$ | $ | ||||||||||||||
|
|
|
|
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Allowance for credit losses: |
||||||||||||||||
Beginning balance |
$ | $ | $ | $ | ||||||||||||
Cumulative effect of change in accounting |
||||||||||||||||
Provision |
( |
) | ( |
) | ||||||||||||
Write-offs |
||||||||||||||||
Recoveries |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Ending balance |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(Amounts in millions) |
2021 |
2020 |
2019 |
2018 |
2017 |
2016 and prior |
Total |
|||||||||||||||||||||
Debt-to-value: |
||||||||||||||||||||||||||||
0% - 50% |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
51% - 60% |
||||||||||||||||||||||||||||
61% - 75% |
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Debt service coverage ratio: |
||||||||||||||||||||||||||||
Less than 1.00 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
1.00 - 1.25 |
||||||||||||||||||||||||||||
1.26 - 1.50 |
||||||||||||||||||||||||||||
1.51 - 2.00 |
||||||||||||||||||||||||||||
Greater than 2.00 |
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2021 |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
Greater than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Office |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Weighted-average debt service coverage ratio |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2020 |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
Greater than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Office |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Weighted-average debt service coverage ratio |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2021 |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
Greater than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Office |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Weighted-average debt-to-value |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2020 |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
Greater than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Office |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Weighted-average debt-to-value |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Derivative assets |
Derivative liabilities |
|||||||||||||||||||
Balance sheet classification |
Fair value |
Balance sheet classification |
Fair value |
|||||||||||||||||
(Amounts in millions) |
September 30, 2021 |
December 31, 2020 |
September 30, 2021 |
December 31, 2020 |
||||||||||||||||
Derivatives designated as hedges |
||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||
Interest rate swaps |
Other invested assets | $ | $ | Other liabilities | $ | $ | ||||||||||||||
Foreign currency swaps |
Other invested assets | Other liabilities | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total cash flow hedges |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives designated as hedges |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
Equity index options |
Other invested assets | Other liabilities | ||||||||||||||||||
Financial futures |
Other invested assets | Other liabilities | ||||||||||||||||||
Other foreign currency contracts |
Other invested assets | Other liabilities | ||||||||||||||||||
GMWB embedded derivatives |
Reinsurance recoverable (1) |
Policyholder account balances (2) |
||||||||||||||||||
Fixed index annuity embedded derivatives |
Other assets | Policyholder account balances (3) |
||||||||||||||||||
Indexed universal life embedded derivatives |
Reinsurance recoverable | Policyholder account balances (4) |
||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives not designated as hedges |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives |
$ | $ | $ | $ | ||||||||||||||||
|
|
|
|
|
|
|
|
(1) |
Represents embedded derivatives associated with the reinsured portion of our guaranteed minimum withdrawal benefits (“GMWB”) liabilities. |
(2) |
Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
(3) |
Represents the embedded derivatives associated with our fixed index annuity liabilities. |
(4) |
Represents the embedded derivatives associated with our indexed universal life liabilities. |
(Notional in millions) |
Measurement |
December 31, 2020 |
Additions |
Maturities/ terminations |
September 30, 2021 |
|||||||||||||||
Derivatives designated as hedges |
||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||
Interest rate swaps |
Notional | $ | $ | $ | ( |
) | $ | |||||||||||||
Foreign currency swaps |
Notional | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total cash flow hedges |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives designated as hedges |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
Interest rate swaps |
Notional | ( |
) | |||||||||||||||||
Equity index options |
Notional | ( |
) | |||||||||||||||||
Financial futures |
Notional | ( |
) | |||||||||||||||||
Other foreign currency contracts |
Notional | ( |
) | |||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives not designated as hedges |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives |
$ | $ | $ | ( |
) | $ | ||||||||||||||
|
|
|
|
|
|
|
|
(Number of policies) |
Measurement |
December 31, 2020 |
Additions |
Maturities/ terminations |
September 30, 2021 |
|||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
GMWB embedded derivatives |
Policies | |
( |
) | ||||||||||||||||
Fixed index annuity embedded derivatives |
Policies | ( |
) | |
||||||||||||||||
Indexed universal life embedded derivatives |
Policies | ( |
) |
(Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income (loss) from OCI |
Classification of gain (loss) reclassified into net income (loss) |
Gain (loss) recognized in net income (loss) |
Classification of gain (loss) recognized in net income (loss) | |||||||||||
Interest rate swaps hedging assets |
$ | $ | Net investment income | $ | Net investment gains (losses) | |||||||||||
Interest rate swaps hedging assets |
Net investment gains (losses) | Net investment gains (losses) | ||||||||||||||
Interest rate swaps hedging liabilities |
( |
) | Interest expense | Net investment gains (losses) | ||||||||||||
Foreign currency swaps |
Net investment income | Net investment gains (losses) | ||||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | $ | $ | |||||||||||||
|
|
|
|
|
|
(Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income (loss) from OCI |
Classification of gain (loss) reclassified into net income (loss) |
Gain (loss) recognized in net income (loss) |
Classification of gain (loss) recognized in net income (loss) | |||||||||||
Interest rate swaps hedging assets |
$ | ( |
) | $ | Net investment income | $ | Net investment gains (losses) | |||||||||
Interest rate swaps hedging assets |
Net investment gains (losses) | Net investment gains (losses) | ||||||||||||||
Interest rate swaps hedging liabilities |
Interest expense | Net investment gains (losses) | ||||||||||||||
Foreign currency swaps |
( |
) | Net investment income | Net investment gains (losses) | ||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | ( |
) | $ | $ | |||||||||||
|
|
|
|
|
|
(Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income (loss) from OCI |
Classification of gain (loss) reclassified into net income (loss) |
Gain (loss) recognized in net income (loss) |
Classification of gain (loss) recognized in net income (loss) | |||||||||||
Interest rate swaps hedging assets |
$ | ( |
) | $ | Net investment income | $ | Net investment gains (losses) | |||||||||
Interest rate swaps hedging assets |
Net investment gains (losses) | Net investment gains (losses) | ||||||||||||||
Interest rate swaps hedging liabilities |
( |
) | Interest expense | Net investment gains (losses) | ||||||||||||
Foreign currency swaps |
Net investment income | Net investment gains (losses) | ||||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | ( |
) | $ | $ | |||||||||||
|
|
|
|
|
|
(Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income (loss) from OCI |
Classification of gain (loss) reclassified into net income (loss) |
Gain (loss) recognized in net income (loss) |
Classification of gain (loss) recognized in net income (loss) | |||||||||||
Interest rate swaps hedging assets |
$ | $ | Net investment income | $ | Net investment gains (losses) | |||||||||||
Interest rate swaps hedging assets |
Net investment gains (losses) | Net investment gains (losses) | ||||||||||||||
Interest rate swaps hedging liabilities |
( |
) | Interest expense | Net investment gains (losses) | ||||||||||||
Foreign currency swaps |
Net investment income | Net investment gains (losses) | ||||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | $ | $ | |||||||||||||
|
|
|
|
|
|
Three months ended September 30, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Derivatives qualifying as effective accounting hedges as of July 1 |
$ | $ | ||||||
Current period increases (decreases) in fair value, net of deferred taxes of $( |
( |
) | ||||||
Reclassification to net (income) loss, net of deferred taxes of $ |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Derivatives qualifying as effective accounting hedges as of September 30 |
$ | $ | ||||||
|
|
|
|
Nine months ended September 30, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Derivatives qualifying as effective accounting hedges as of January 1 |
$ | $ | ||||||
Current period increases (decreases) in fair value, net of deferred taxes of $ |
( |
) | ||||||
Reclassification to net (income) loss, net of deferred taxes of $ |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Derivatives qualifying as effective accounting hedges as of September 30 |
$ | $ | ||||||
|
|
|
|
Three months ended September 30, |
Classification of gain (loss) recognized in net income (loss) | |||||||||
(Amounts in millions) |
2021 |
2020 |
||||||||
Interest rate swaps |
$ | ( |
) | $ | Net investment gains (losses) | |||||
Equity index options |
Net investment gains (losses) | |||||||||
Financial futures |
( |
) | Net investment gains (losses) | |||||||
Other foreign currency contracts |
( |
) | Net investment gains (losses) | |||||||
GMWB embedded derivatives |
( |
) | Net investment gains (losses) | |||||||
Fixed index annuity embedded derivatives |
( |
) | ( |
) | Net investment gains (losses) | |||||
Indexed universal life embedded derivatives |
Net investment gains (losses) | |||||||||
Total derivatives not designated as hedges |
$ | ( |
) | $ | ||||||
Nine months ended September 30, |
Classification of gain (loss) recognized in net income (loss) | |||||||||
(Amounts in millions) |
2021 |
2020 |
||||||||
Interest rate swaps |
$ | $ | ( |
) | Net investment gains (losses) | |||||
Equity index options |
( |
) | Net investment gains (losses) | |||||||
Financial futures |
( |
) | Net investment gains (losses) | |||||||
Other foreign currency contracts |
Net investment gains (losses) | |||||||||
GMWB embedded derivatives |
( |
) | Net investment gains (losses) | |||||||
Fixed index annuity embedded derivatives |
( |
) | ( |
) | Net investment gains (losses) | |||||
Indexed universal life embedded derivatives |
Net investment gains (losses) | |||||||||
Total derivatives not designated as hedges |
$ | $ | ( |
) | ||||||
September 30, 2021 |
December 31, 2020 |
|||||||||||||||||||||||
(Amounts in millions) |
Derivative assets (1) |
Derivative liabilities (1) |
Net derivatives |
Derivative assets (1) |
Derivative liabilities (1) |
Net derivatives |
||||||||||||||||||
Amounts presented in the balance sheet: |
||||||||||||||||||||||||
Gross amounts recognized |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Gross amounts offset in the balance sheet |
||||||||||||||||||||||||
Net amounts presented in the balance sheet |
||||||||||||||||||||||||
Gross amounts not offset in the balance sheet: |
||||||||||||||||||||||||
Financial instruments (2) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Collateral received |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Collateral pledged |
( |
) | ( |
) | ||||||||||||||||||||
Over collateralization |
( |
) | ( |
) | ||||||||||||||||||||
Net amount |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
(1) |
Included $ |
(2) |
Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. |
• | Third-party pricing services: |
(Amounts in millions) |
Fair value |
Primary methodologies |
Significant inputs | |||||
U.S. government, agencies and government-sponsored enterprises |
$ | |||||||
State and political subdivisions |
$ | |||||||
Non-U.S. government |
$ | |||||||
U.S. corporate |
$ | |||||||
Non-U.S. corporate |
$ | |||||||
Residential mortgage-backed |
$ | |||||||
Commercial mortgage-backed |
$ | |||||||
Other asset-backed |
$ |
• | Internal models: non-U.S. corporate securities are valued using internal models. The fair value of these fixed maturity securities was $ |
• | Broker quotes: non-U.S. corporate, residential mortgage-backed, commercial mortgage-backed and other asset-backed securities are valued using broker quotes. Broker quotes are obtained from third-party providers that have current market knowledge to provide a reasonable price for securities not routinely priced by pricing services. Brokers utilized for valuation of assets are reviewed annually. The fair value of our Level 3 fixed maturity securities priced by broker quotes was $ |
• | Internal models: non-U.S. corporate, residential mortgage-backed and other asset-backed securities are valued using internal models. The primary inputs to the valuation of the bond population include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, duration, call provisions, issuer rating, benchmark yields and credit spreads. Certain private fixed maturity securities are valued using an internal model using market observable inputs such as the interest rate yield curve, as well as published credit spreads for similar securities, which includes significant unobservable inputs. Additionally, we may apply certain price caps and liquidity premiums in the valuation of private fixed maturity securities. Price caps are established using inputs from market participants. For structured securities, the primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, weighted-average coupon, weighted-average maturity, issuer rating, structure of the security, expected prepayment speeds and volumes, collateral type, current and forecasted loss severity, average delinquency rates, vintage of the loans, geographic region, debt service coverage ratios, payment priority with the tranche, benchmark yields and credit spreads. The fair value of our Level 3 fixed maturity securities priced using internal models was $ |
September 30, 2021 |
||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
State and political subdivisions |
||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total U.S. corporate |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total non-U.S. corporate |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Residential mortgage-backed |
||||||||||||||||||||
Commercial mortgage-backed |
||||||||||||||||||||
Other asset-backed |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total fixed maturity securities |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Equity securities |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other invested assets: |
||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Interest rate swaps |
||||||||||||||||||||
Foreign currency swaps |
||||||||||||||||||||
Equity index options |
||||||||||||||||||||
Other foreign currency contracts |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total derivative assets |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Short-term investments |
||||||||||||||||||||
Limited partnerships |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other invested assets |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance recoverable (2) |
||||||||||||||||||||
Separate account assets |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
$ | $ | $ | $ | $ | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
December 31, 2020 |
||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
State and political subdivisions |
||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total U.S. corporate |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total non-U.S. corporate |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Residential mortgage-backed |
||||||||||||||||||||
Commercial mortgage-backed |
||||||||||||||||||||
Other asset-backed |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total fixed maturity securities |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Equity securities |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other invested assets: |
||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Interest rate swaps |
||||||||||||||||||||
Foreign currency swaps |
||||||||||||||||||||
Equity index options |
||||||||||||||||||||
Other foreign currency contracts |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total derivative assets |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Securities lending collateral |
||||||||||||||||||||
Short-term investments |
||||||||||||||||||||
Limited partnerships |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other invested assets |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance recoverable (2) |
||||||||||||||||||||
Separate account assets |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
$ | $ | $ | $ | $ | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
(Amounts in millions) |
Beginning balance as of July 1, 2021 |
Total realized and unrealized gains (losses) |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 (1) |
Transfer out of Level 3 (1) |
Ending balance as of September 30, 2021 |
Total gains (losses) attributable to assets still held |
||||||||||||||||||||||||||||||||||||||
Included in net income (loss) |
Included in OCI |
Included in net income (loss) |
Included in OCI |
|||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
||||||||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
||||||||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total fixed maturity securities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Equity securities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Equity index options |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total derivative assets |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total other invested assets |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Reinsurance recoverable (2) |
||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 assets |
$ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
(Amounts in millions) |
Beginning balance as of July 1, 2020 |
Total realized and unrealized gains (losses) |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 (1) |
Transfer out of Level 3 (1) |
Ending balance as of September 30, 2020 |
Total gains (losses) attributable to assets still held |
||||||||||||||||||||||||||||||||||||||
Included in net income (loss) |
Included in OCI |
Included in net income (loss) |
Included in OCI |
|||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | $ | ( |
) | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
||||||||||||||||||||||||||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
||||||||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total U.S. corporate |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Energy |
||||||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
||||||||||||||||||||||||||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total fixed maturity securities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Equity securities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Equity index options |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total derivative assets |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total other invested assets |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Reinsurance recoverable (2) |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 assets |
$ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
(Amounts in millions) |
Beginning balance as of January 1, 2021 |
Total realized and unrealized gains (losses) |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 (1) |
Transfer out of Level 3 (1) |
Ending balance as of September 30, 2021 |
Total gains (losses) attributable to assets still held |
||||||||||||||||||||||||||||||||||||||
Included in net income (loss) |
Included in OCI |
Included in net income (loss) |
Included in OCI |
|||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
||||||||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Capital goods |
||||||||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total fixed maturity securities |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Equity securities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Equity index options |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total derivative assets |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total other invested assets |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Reinsurance recoverable (2) |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 assets |
$ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
(Amounts in millions) |
Beginning balance as of January 1, 2020 |
Total realized and unrealized gains (losses) |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 (1) |
Transfer out of Level 3 (1) |
Ending balance as of September 30, 2020 |
Total gains (losses) attributable to assets still held |
||||||||||||||||||||||||||||||||||||||
Included in net income (loss) |
Included in OCI |
Included in net income (loss) |
Included in OCI |
|||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
||||||||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total fixed maturity securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Equity securities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Equity index options |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total derivative assets |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total other invested assets |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Reinsurance recoverable (2) |
||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 assets |
$ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Total realized and unrealized gains (losses) included in net income (loss): |
||||||||||||||||
Net investment income |
$ | $ | $ | $ | ||||||||||||
Net investment gains (losses) |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total gains (losses) included in net income (loss) attributable to assets still held: |
||||||||||||||||
Net investment income |
$ | $ | $ | $ | ||||||||||||
Net investment gains (losses) |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | $ | ( |
) | $ | $ | ||||||||||
|
|
|
|
|
|
|
|
(Amounts in millions) |
Valuation technique |
Fair value |
Unobservable input |
Range |
Weighted- average (1) |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
$ | Credit spreads | ||||||||||||||||||
Energy |
Credit spreads | |||||||||||||||||||
Finance and insurance |
Credit spreads | |||||||||||||||||||
Consumer—non-cyclical |
Credit spreads | |||||||||||||||||||
Technology and communications |
Credit spreads | |||||||||||||||||||
Industrial |
Credit spreads | |||||||||||||||||||
Capital goods |
Credit spreads | |||||||||||||||||||
Consumer—cyclical |
Credit spreads | |||||||||||||||||||
Transportation |
Credit spreads | |||||||||||||||||||
Other |
Credit spreads | |||||||||||||||||||
|
|
|||||||||||||||||||
Total U.S. corporate |
$ | Credit spreads | ||||||||||||||||||
|
|
|||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
$ | Credit spreads | ||||||||||||||||||
Energy |
Credit spreads | |||||||||||||||||||
Finance and insurance |
Credit spreads | |||||||||||||||||||
Consumer—non-cyclical |
Credit spreads | |||||||||||||||||||
Technology and communications |
Credit spreads | |||||||||||||||||||
Industrial |
Credit spreads | |||||||||||||||||||
Capital goods |
Credit spreads | |||||||||||||||||||
Consumer—cyclical |
Credit spreads | |||||||||||||||||||
Transportation |
Credit spreads | |||||||||||||||||||
Other |
Credit spreads | |||||||||||||||||||
|
|
|||||||||||||||||||
Total non-U.S. corporate |
$ | Credit spreads | ||||||||||||||||||
|
|
|||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Equity index options |
cash flows |
|
$ | Equity index volatility |
|
(1) |
Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities and by notional for derivative assets. |
September 30, 2021 |
||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Liabilities |
||||||||||||||||
Policyholder account balances: |
||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | ||||||||||||
Fixed index annuity embedded derivatives |
||||||||||||||||
Indexed universal life embedded derivatives |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total policyholder account balances |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative liabilities: |
||||||||||||||||
Interest rate swaps |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total derivative liabilities |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
December 31, 2020 |
||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Liabilities |
||||||||||||||||
Policyholder account balances: |
||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | ||||||||||||
Fixed index annuity embedded derivatives |
||||||||||||||||
Indexed universal life embedded derivatives |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total policyholder account balances |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative liabilities: |
||||||||||||||||
Interest rate swaps |
||||||||||||||||
Foreign currency swaps |
||||||||||||||||
Other foreign currency contracts |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total derivative liabilities |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Beginning balance as of July 1, 2021 |
Total realized and unrealized (gains) losses |
Transfer into Level 3 |
Transfer out of Level 3 |
Ending balance as of September 30, 2021 |
Total (gains) losses attributable to liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net (income) loss |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Included in net (income) loss |
Included in OCI |
||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Beginning balance as of July 1, 2020 |
Total realized and unrealized (gains) losses |
Transfer into Level 3 |
Transfer out of Level 3 |
Ending balance as of September 30, 2020 |
Total (gains) losses attributable to liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net (income) loss |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Included in net (income) loss |
Included in OCI |
||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | ( |
) | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | ( |
) | $ | $ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Beginning balance as of January 1, 2021 |
Total realized and unrealized (gains) losses |
Transfer into Level 3 |
Transfer out of Level 3 |
Ending balance as of September 30, 2021 |
Total (gains) losses attributable to liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net (income) loss |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Included in net (income) loss |
Included in OCI |
||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | ( |
) | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | ( |
) | $ | $ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Beginning balance as of January 1, 2020 |
Total realized and unrealized (gains) losses |
Transfer into Level 3 |
Transfer out of Level 3 |
Ending balance as of September 30, 2020 |
Total (gains) losses attributable to liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net (income) loss |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Included in net (income) loss |
Included in OCI |
||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Total realized and unrealized (gains) losses included in net (income) loss: |
||||||||||||||||
Net investment income |
$ | $ | $ | $ | ||||||||||||
Net investment (gains) losses |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | $ | ( |
) | $ | ( |
) | $ | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total (gains) losses included in net (income) loss attributable to liabilities still held: |
||||||||||||||||
Net investment income |
$ | $ | $ | $ | ||||||||||||
Net investment (gains) losses |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | $ | ( |
) | $ | ( |
) | $ | ||||||||
|
|
|
|
|
|
|
|
(Amounts in millions) |
Valuation technique |
Fair value |
Unobservable input |
Range |
Weighted- average (1) | |||||||
Policyholder account balances: |
||||||||||||
Withdrawal utilization rate | ||||||||||||
Lapse rate | ||||||||||||
Non-performance risk (credit spreads) |
||||||||||||
GMWB embedded derivatives (2) |
$ | Equity index volatility | ||||||||||
Fixed index annuity embedded derivatives |
$ | Expected future interest credited | ||||||||||
Indexed universal life embedded derivatives |
$ | Expected future interest credited |
(1) |
Unobservable inputs weighted by the policyholder account balances associated with the instrument. |
(2) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs. |
September 30, 2021 |
||||||||||||||||||||||||
Notional amount |
Carrying amount |
Fair value |
||||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||||||||||
Assets: |
||||||||||||||||||||||||
Commercial mortgage loans, net |
(1) |
$ | $ | $ | $ | $ | ||||||||||||||||||
Bank loan investments |
(1) |
|||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||
Long-term borrowings |
(1) |
|||||||||||||||||||||||
Investment contracts |
(1) |
|||||||||||||||||||||||
Other firm commitments: |
||||||||||||||||||||||||
Commitments to fund limited partnerships |
||||||||||||||||||||||||
Commitments to fund bank loan investments |
||||||||||||||||||||||||
Ordinary course of business lending commitments |
(1) |
These financial instruments do not have notional amounts. |
December 31, 2020 |
||||||||||||||||||||||||
Notional amount |
Carrying amount |
Fair value |
||||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||||||||||
Assets: |
||||||||||||||||||||||||
Commercial mortgage loans, net |
(1) |
$ | $ | $ | $ | $ | ||||||||||||||||||
Bank loan investments |
(1) |
|||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||
Long-term borrowings |
(1) |
|||||||||||||||||||||||
Investment contracts |
(1) |
|||||||||||||||||||||||
Other firm commitments: |
||||||||||||||||||||||||
Commitments to fund limited partnerships |
||||||||||||||||||||||||
Commitments to fund bank loan investments |
||||||||||||||||||||||||
Ordinary course of business lending commitments |
(1) |
These financial instruments do not have notional amounts. |
As of or for the nine months ended September 30, |
||||||||
(Amounts in millions) |
2021 |
2020 |
||||||
Beginning balance |
$ | $ | ||||||
Less reinsurance recoverables |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net beginning balance |
||||||||
|
|
|
|
|||||
Incurred related to insured events of: |
||||||||
Current year |
||||||||
Prior years |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total incurred |
||||||||
|
|
|
|
|||||
Paid related to insured events of: |
||||||||
Current year |
( |
) | ( |
) | ||||
Prior years |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total paid |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Interest on liability for policy and contract claims |
||||||||
Foreign currency translation |
( |
) | ||||||
|
|
|
|
|||||
Net ending balance |
||||||||
Add reinsurance recoverables |
||||||||
|
|
|
|
|||||
Ending balance |
$ | $ | ||||||
|
|
|
|
(Amounts in millions) |
September 30, 2021 |
December 31, 2020 |
||||||
Genworth Holdings (1) |
||||||||
$ | $ | |||||||
Floating Rate Junior Subordinated Notes, due |
||||||||
Subtotal |
||||||||
Bond consent fees |
( |
) | ( |
) | ||||
Deferred borrowing charges |
( |
) | ( |
) | ||||
Total Genworth Holdings |
||||||||
Enact Holdings |
||||||||
(2) |
||||||||
Deferred borrowing charges |
( |
) | ( |
) | ||||
Total Enact Holdings |
||||||||
Total |
$ | $ | ||||||
(1) |
We have the option to redeem all or a portion of the senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread. |
(2) |
Senior notes issued by Enact Holdings, our majority-owned U.S. mortgage insurance subsidiary, who has the option to redeem the notes in whole or in part at any time prior to February 15, 2025, by paying a make-whole premium plus accrued and unpaid interest. |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Statutory U.S. federal income tax rate |
% | % | % | % | ||||||||||||
Increase (reduction) in rate resulting from: |
||||||||||||||||
Swaps terminated prior to the TCJA (1) |
||||||||||||||||
Reduction in uncertain tax positions |
( |
) | ( |
) | ||||||||||||
Other, net |
||||||||||||||||
Effective rate |
% | % | % | % | ||||||||||||
(1) |
Tax Cuts and Jobs Act. |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Revenues: |
||||||||||||||||
Enact segment |
$ | $ | $ | $ | ||||||||||||
U.S. Life Insurance segment: |
||||||||||||||||
Long-term care insurance |
||||||||||||||||
Life insurance |
||||||||||||||||
Fixed annuities |
||||||||||||||||
U.S. Life Insurance segment |
||||||||||||||||
Runoff segment |
||||||||||||||||
Corporate and Other activities |
( |
) | ||||||||||||||
Total revenues |
$ | $ | $ | $ | ||||||||||||
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ( |
) | ||||||||||
Add: net income from continuing operations attributable to noncontrolling interests |
||||||||||||||||
Add: net income from discontinued operations attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
( |
) | ||||||||||||||
Less: income (loss) from discontinued operations, net of taxes |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from continuing operations |
||||||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
||||||||||||||||
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Net investment (gains) losses, net (1) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
(Gains) losses on early extinguishment of debt |
||||||||||||||||
Expenses related to restructuring |
||||||||||||||||
Taxes on adjustments |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(1) |
For the three and nine months ended September 30, 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $ |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Enact segment |
$ | $ | $ | $ | ||||||||||||
U.S. Life Insurance segment: |
||||||||||||||||
Long-term care insurance |
||||||||||||||||
Life insurance |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Fixed annuities |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
U.S. Life Insurance segment |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Runoff segment |
||||||||||||||||
Corporate and Other activities |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(Amounts in millions) |
September 30, 2021 |
December 31, 2020 |
||||||
Assets: |
||||||||
Enact segment |
$ | $ | ||||||
U.S. Life Insurance segment |
||||||||
Runoff segment |
||||||||
Corporate and Other activities |
||||||||
|
|
|
|
|||||
Segment assets from continuing operations |
||||||||
Assets related to discontinued operations |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
(Amounts in millions) |
Net unrealized investment gains (losses) (1) |
Derivatives qualifying as hedges (2) |
Foreign currency translation and other adjustments |
Total |
||||||||||||
Balances as of July 1, 2021 |
$ | $ | $ | ( |
) | $ | ||||||||||
OCI before reclassifications |
( |
) | ||||||||||||||
Amounts reclassified from (to) OCI |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Current period OCI |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of September 30, 2021 before noncontrolling interests |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Less: change in OCI attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of September 30, 2021 |
$ | $ | $ | ( |
) | $ | ||||||||||
|
|
|
|
|
|
|
|
(1) |
Net of adjustments to DAC, present value of future profits, sales inducements and benefit reserves. See note 4 for additional information. |
(2) |
See note 5 for additional information. |
(Amounts in millions) |
Net unrealized investment gains (losses) (1) |
Derivatives qualifying as hedges (2) |
Foreign currency translation and other adjustments |
Total |
||||||||||||
Balances as of July 1, 2020 |
$ | $ | $ | ( |
) | $ | ||||||||||
OCI before reclassifications |
( |
) | ||||||||||||||
Amounts reclassified from (to) OCI |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Current period OCI |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of September 30, 2020 before noncontrolling interests |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Less: change in OCI attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of September 30, 2020 |
$ | $ | $ | ( |
) | $ | ||||||||||
|
|
|
|
|
|
|
|
(1) |
Net of adjustments to DAC, present value of future profits, sales inducements and benefit reserves. See note 4 for additional information. |
(2) |
See note 5 for additional information. |
(Amounts in millions) |
Net unrealized investment gains (losses) (1) |
Derivatives qualifying as hedges (2) |
Foreign currency translation and other adjustments |
Total |
||||||||||||
Balances as of January 1, 2021 |
$ | $ | $ | $ | ||||||||||||
OCI before reclassifications |
( |
) | ( |
) | ( |
) | ||||||||||
Amounts reclassified from (to) OCI |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Current period OCI |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of September 30, 2021 before noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Less: change in OCI attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of September 30, 2021 |
$ | $ | $ | ( |
) | $ | ||||||||||
|
|
|
|
|
|
|
|
(1) |
Net of adjustments to DAC, present value of future profits, sales inducements and benefit reserves. See note 4 for additional information. |
(2) |
See note 5 for additional information. |
(Amounts in millions) |
Net unrealized investment gains (losses) (1) |
Derivatives qualifying as hedges (2) |
Foreign currency translation and other adjustments |
Total |
||||||||||||
Balances as of January 1, 2020 |
$ | $ | $ | ( |
) | $ | ||||||||||
OCI before reclassifications |
||||||||||||||||
Amounts reclassified from (to) OCI |
( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Current period OCI |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of September 30, 2020 before noncontrolling interests |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Less: change in OCI attributable to noncontrolling interests |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balances as of September 30, 2020 |
$ | $ | $ | ( |
) | $ | ||||||||||
|
|
|
|
|
|
|
|
(1) |
Net of adjustments to DAC, present value of future profits, sales inducements and benefit reserves. See note 4 for additional information. |
(2) |
See note 5 for additional information. |
Amount reclassified from accumulated other comprehensive income (loss) |
Affected line item in the consolidated statements of income | |||||||||||||||||
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||||
Net unrealized investment (gains) losses: |
||||||||||||||||||
Unrealized (gains) losses on investments (1) |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | Net investment (gains) losses | |||||
Income taxes |
Provision for income taxes | |||||||||||||||||
Total |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
Derivatives qualifying as hedges: |
||||||||||||||||||
Interest rate swaps hedging assets |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | Net investment income | |||||
Interest rate swaps hedging assets |
( |
) | ( |
) | ( |
) | ( |
) | Net investment (gains) losses | |||||||||
Interest rate swaps hedging liabilities |
Interest expense | |||||||||||||||||
Income taxes |
Provision for income taxes | |||||||||||||||||
Total |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
(1) |
Amounts exclude adjustments to DAC, present value of future profits, |
(Amounts in millions) |
Three months ended September 30, 2021 |
Nine months ended September 30, 2021 |
||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
Transfers to noncontrolling interests: |
||||||||
Decrease in Genworth Financial, Inc.’s additional paid-in capital for initial sale of Enact Holdings to noncontrolling interests |
( |
) | ( |
) | ||||
Net transfers to noncontrolling interests |
( |
) | ( |
) | ||||
Change from net income available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests |
$ | $ | ||||||
(Amounts in millions) |
June 30, 2021 |
December 31, 2020 |
||||||
Assets |
||||||||
Investments: |
||||||||
Fixed maturity securities available-for-sale, |
$ | $ | ||||||
Equity securities, at fair value |
||||||||
Other invested assets |
||||||||
|
|
|
|
|||||
Total investments |
||||||||
Cash, cash equivalents and restricted cash |
||||||||
Accrued investment income |
||||||||
Deferred acquisition costs |
||||||||
Intangible assets |
||||||||
Other assets |
||||||||
Deferred tax asset |
||||||||
|
|
|
|
|||||
Assets related to discontinued operations |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities |
||||||||
Liability for policy and contract claims |
$ | $ | ||||||
Unearned premiums |
||||||||
Other liabilities |
||||||||
Long-term borrowings |
||||||||
|
|
|
|
|||||
Liabilities related to discontinued operations |
$ | $ | ||||||
|
|
|
|
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | $ | $ | $ | ||||||||||||
Net investment income |
||||||||||||||||
Net investment gains (losses) |
( |
) | ||||||||||||||
Policy fees and other income |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenues |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
||||||||||||||||
Acquisition and operating expenses, net of deferrals |
||||||||||||||||
Amortization of deferred acquisition costs and intangibles |
||||||||||||||||
Goodwill impairment |
||||||||||||||||
Interest expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total benefits and expenses |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income before income taxes and gain ( loss) on sale (1) |
||||||||||||||||
Provision for income taxes |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income before gain ( loss) on sale |
||||||||||||||||
Gain (loss) on sale, net of taxes |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from discontinued operations, net of taxes |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(1) |
The three months ended September 30, 2020, includes pre-tax income from discontinued operations available to Genworth Financial, Inc.’s common stockholders of $pre-tax income from discontinued operations available to Genworth Financial, Inc.’s common stockholders of $ |
(Amounts in millions) |
British Pounds |
U.S. Dollar |
||||||||||||||
September 30, 2021 |
December 31, 2020 |
September 30, 2021 |
December 31, 2020 |
|||||||||||||
Installment payments due to AXA: |
||||||||||||||||
June 2022: |
||||||||||||||||
Beginning balance |
£ | £ | $ | $ | ||||||||||||
Prepayments (1) |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Ending balance |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
September 2022: |
||||||||||||||||
Beginning balance |
||||||||||||||||
Amounts billed as future losses |
||||||||||||||||
Foreign exchange and other |
||||||||||||||||
Prepayments (1) |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Ending balance |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total amounts due under the promissory note |
||||||||||||||||
Future claims: |
||||||||||||||||
Estimated beginning balance |
||||||||||||||||
Change in estimated future claims |
( |
) | ( |
) | ||||||||||||
Foreign exchange and other |
( |
) | ||||||||||||||
Less: Amounts billed |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Estimated future billings |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total amounts due to AXA under the settlement agreement |
£ | £ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(1) |
On March 3, 2021, we completed the sale of Genworth Australia and received net proceeds of approximately AUD |
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
• | we may be unable to successfully execute our strategic plans |
• | risks relating to estimates, assumptions and valuations COVID-19; inaccurate models; deviations from our estimates and actuarial assumptions or other reasons in our long-term care insurance, life insurance and/or annuity businesses; accelerated amortization of deferred acquisition costs (“DAC”) and present value of future profits (“PVFP”) (including as a result of any changes we may make to our assumptions, methodologies or otherwise in connection with periodic or other reviews, including reviews we expect to complete and carry out in the fourth quarter of 2021); adverse impact on our financial results as a result of projected profits followed by projected losses (as is currently the case with our long-term care insurance business); and changes in valuation of fixed maturity and equity securities; |
• | liquidity, financial strength ratings, credit and counterparty risks COVID-19; continued availability of capital and financing; future adverse rating agency actions against us or Enact Holdings, including with respect to rating downgrades or potential downgrades or being put on review for potential downgrade, all of which could have adverse implications, including with respect to key business relationships, product offerings, business results of operations, financial condition and capital needs, strategic plans, collateral obligations and availability and terms of hedging, reinsurance and borrowings; defaults by counterparties to reinsurance arrangements or derivative instruments; defaults or other events impacting the value of our fixed maturity securities portfolio; defaults on our commercial mortgage loans; defaults on mortgage loans or other assets underlying our investments in our mortgage-backed and asset-backed securities and volatility in performance; |
• | risks relating to economic, market and political conditions COVID-19; interest rates and changes in rates have adversely impacted, and may continue to materially adversely impact our business and profitability; deterioration in economic conditions or a decline in home prices that adversely affect our loss experience in our Enact segment; political and economic instability or changes in government policies; and fluctuations in foreign currency exchange rates and international securities markets; |
• | regulatory and legal risks COVID-19, and other insurance, regulatory or corporate law restrictions; the inability to successfully seek in-force rate action increases (including increased premiums and associated benefit reductions) in our long-term care insurance business, including as a result of COVID-19; adverse changes in regulatory requirements, including risk-based capital; inability to continue to maintain the private mortgage insurer eligibility requirements (“PMIERs”); risks on Enact Holdings’ ability to pay our holding company dividends as a result of the government-sponsored enterprises’ (“GSEs”) amendments to PMIERs in response to COVID-19 or additional PMIERs requirements or other restrictions that the GSEs may place on the ability of Enact Holdings to pay dividends to our holding company; the impact on capital levels of increased delinquencies caused by COVID-19; inability of our U.S. mortgage insurance subsidiaries to meet minimum statutory capital requirements; the influence of Federal National Mortgage Association (“Fannie Mae”), Federal Home Loan Mortgage Corporation (“Freddie Mac”) and a small number of large mortgage lenders in the U.S. mortgage insurance market and adverse changes to the role or structure of Fannie Mae and Freddie Mac; adverse changes in regulations affecting our Enact segment; additional restrictions placed on our Enact segment by government and government-owned enterprises and the GSEs in connection with additional capital transactions; inability to continue to implement actions to mitigate the impact of statutory reserve requirements; changes in tax laws; and changes in accounting and reporting standards; |
• | operational risks shelter-in-place COVID-19; reliance on, and loss of, key customer or distribution relationships; the design and effectiveness of our disclosure controls and procedures and internal control over financial reporting may not prevent all errors, misstatements or misrepresentations; and failure or any compromise of the security of our computer systems, disaster recovery systems, business continuity plans and failures to safeguard or breaches of confidential information; |
• | insurance and product-related risks in-force long-term care insurance policies, in each case, as currently anticipated and as may be required from time to time in the future (including as a result of a delay or failure to obtain any necessary regulatory approvals, including as a result of COVID-19, or unwillingness or inability of policyholders to pay increased premiums and/or accept reduced benefits), including to offset any negative impact on our long-term care insurance margins; availability, affordability and adequacy of reinsurance to protect us against losses; decreases in the volume of mortgage originations or increases in mortgage insurance cancellations; increases in the use of alternatives to private mortgage insurance and reductions in the level of coverage selected; potential liabilities in connection with our U.S. contract underwriting services; and medical advances, such as genetic research and diagnostic imaging, and related legislation that impact policyholder behavior in ways adverse to us; |
• | other risks man-made disasters or a pandemic, similar to COVID-19, could materially adversely affect our financial condition and results of operations. |
• | Net income available to Genworth Financial, Inc.’s common stockholders was $314 million and $418 million for the three months ended September 30, 2021 and 2020, respectively. Adjusted operating income available to Genworth Financial, Inc.’s common stockholders was $239 million and $125 million for the three months ended September 30, 2021 and 2020, respectively. |
• | Our Enact segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $134 million and $141 million for the three months ended September 30, 2021 and 2020, respectively. The decrease was primarily attributable to lower premiums mainly due to a decrease in single premium policy cancellations, continued lapse of our older higher priced policies and higher ceded premiums, partially offset by higher insurance in-force in the current year. The decrease was also driven by higher interest expense associated with Enact Holdings’ senior notes issued in August 2020 and the minority IPO of Enact Holdings that closed in September 2021, which reduced our ownership percentage to 81.6% and resulted in lower net income of $4 million in the third quarter of 2021. These decreases were partially offset by lower losses mainly from a decrease in new delinquencies in the current year, partially offset by lower reserves of $18 million from favorable development on incurred but not reported (“IBNR”) delinquencies in the prior year that did not recur. |
• | Our U.S. Life Insurance segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $93 million and $14 million for the three months ended September 30, 2021 and 2020, respectively. |
• | Our long-term care insurance business had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $133 million and $59 million for the three months ended September 30, 2021 and 2020, respectively. The increase was primarily from higher premiums and reduced benefits of $66 million in the current year from in-force rate actions approved and implemented, which included a net favorable impact from policyholder benefit reduction elections made as part of a legal settlement in the current year. The increase was also attributable to higher net investment income and favorable development on IBNR claims, partially offset by a decrease in claim terminations driven mostly by lower mortality in the current year. |
• | Our life insurance business had an adjusted operating loss available to Genworth Financial, Inc.’s common stockholders of $68 million and $69 million for the three months ended September 30, |
2021 and 2020, respectively. The decrease in the loss was mainly attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance blocks entering its post-level premium period and from lower lapses primarily associated with our large 20-year term life insurance block written at the end of 2000 as it entered its post-level premium period. These improvements were partially offset by a DAC impairment of $30 million in our term universal life insurance product and higher mortality in our term universal and term life insurance products in the current year. |
• | Our fixed annuities business had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $28 million and $24 million for the three months ended September 30, 2021 and 2020, respectively. The increase was mainly attributable to lower reserves in our fixed indexed annuities driven by favorable changes in interest rates and equity markets in the current year, partially offset by lower mortality in our single premium immediate annuities and by lower net spreads in the current year. |
• | Our Runoff segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $11 million and $19 million for the three months ended September 30, 2021 and 2020, respectively. The decrease was predominantly due to higher mortality in our corporate-owned life insurance products and unfavorable equity market performance in the current year. |
• | Corporate and Other activities had adjusted operating income of $1 million in the current year compared to an adjusted operating loss of $49 million in the prior year. The change to adjusted operating income in the current year from an adjusting operating loss in the prior year was primarily related to lower interest expense and higher tax benefits of $21 million from a reduction in uncertain tax positions due to the expiration of certain statute of limitations in the current year. |
• | Net income available to Genworth Financial, Inc.’s common stockholders was $741 million for the nine months ended September 30, 2021 compared to a net loss of $89 million for the nine months ended September 30, 2020. Adjusted operating income available to Genworth Financial, Inc.’s common stockholders was $601 million and $122 million for the nine months ended September 30, 2021 and 2020, respectively. |
• | Our Enact segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $395 million and $286 million for the nine months ended September 30, 2021 and 2020, respectively. The increase was primarily attributable to lower losses mainly from a decrease in new delinquencies and from lower unfavorable reserve adjustments in the current year. The increase was also driven by higher premiums mainly attributable to higher insurance in-force, partially offset by continued lapse of our older higher priced policies, higher ceded premiums and lower single premium policy cancellations in the current year. These increases were partially offset by higher interest expense associated with Enact Holdings’ senior notes issued in August 2020 and an increase in operating costs in the current year. |
• | Our U.S. Life Insurance segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $226 million in the current year compared to an adjusted operating loss of $61 million in the prior year. |
• | Our long-term care insurance business had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $326 million and $108 million for the nine months ended September 30, 2021 and 2020, respectively. The increase was primarily from higher net investment income, as well as higher premiums and reduced benefits of $141 million in the current year from in-force rate actions approved and implemented, which included a net favorable impact from policyholder benefit reduction elections made as part of a legal settlement in the current year. The increase was also attributable to favorable development on IBNR claims driven by lower incidence in the current year. |
• | Our life insurance business had an adjusted operating loss available to Genworth Financial, Inc.’s common stockholders of $171 million and $227 million for the nine months ended September 30, 2021 and 2020, respectively. The decrease in the loss was mainly attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance block entering its post-level premium period and from lower lapses primarily associated with our large 20-year term life insurance block written at the end of 2000 as it entered its post-level premium period. These improvements were partially offset by higher mortality in our universal and term universal life insurance products and DAC impairments of $60 million in our universal and term universal life insurance products in the current year. |
• | Our fixed annuities business had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $71 million and $58 million for the nine months ended September 30, 2021 and 2020, respectively. The increase was mainly attributable to lower reserves and DAC amortization in our fixed indexed annuities driven by favorable changes in interest rates and equity markets in the current year, partially offset by lower mortality in our single premium immediate annuities and lower net spreads in the current year. |
• | Our Runoff segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $38 million and $30 million for the nine months ended September 30, 2021 and 2020, respectively. The increase was primarily due to favorable equity market and interest rate performance, partially offset by lower investment income in the current year. |
• | Corporate and Other activities had an adjusted operating loss available to Genworth Financial, Inc.’s common stockholders of $58 million and $133 million for the nine months ended September 30, 2021 and 2020, respectively. The decrease in the loss was primarily related to lower interest expense, higher tax benefits of $21 million from a reduction in uncertain tax positions due to the expiration of certain statute of limitations and lower operating costs, partially offset by lower investment income in the current year. |
• | Incurred losses. COVID-19, partially offset by lower reserves of $23 million from favorable development on IBNR delinquencies. |
• | Borrower forbearance. COVID-19. Servicer reported forbearance slowed meaningfully beginning in June 2020 and ended the third quarter of 2021 with approximately 3% or 29,526 of our active primary policies reported in a forbearance plan, of which approximately 55% were reported as delinquent. |
• | PMIERs compliance. |
PMIERs sufficiency was driven in part by the completion of an insurance linked notes transaction, which added $372 million of additional PMIERs capital credit as of September 30, 2021, elevated lapse driven by prevailing low interest rates, business cash flows and lower delinquencies, partially offset by elevated new insurance written and amortization of our reinsurance transactions executed prior to the third quarter of 2021. Our PMIERs required assets as of September 30, 2021 and June 30, 2021 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans. The application of the 0.30 multiplier to all eligible delinquencies provided $570 million of benefit to our September 30, 2021 PMIERs required assets compared to $760 million of benefit as of June 30, 2021. See “Item 2—Enact segment—Trends and conditions” for additional details. |
• | Persistency. in-force policies with mortgage rates above current interest rates. Suppressed persistency has impacted business performance trends in several ways including, but not limited to, offsetting insurance in-force growth from new insurance written, accelerating the recognition of earned premiums due to single premium policy cancellations, accelerating the amortization of our existing reinsurance transactions reducing their associated PMIERs capital credit and shifting the concentration of our primary insurance in-force to more recent years of policy origination. |
• | In-force rate actions in our long-term care insurance business.in-force rate action filings, we received 118 filing approvals from 38 states during the nine months ended September 30, 2021, representing a weighted-average increase of 37% on approximately $871 million in annualized in-force premiums, or approximately $323 million of incremental annual premiums. We also submitted 85 new filings in 25 states during the nine months ended September 30, 2021 on approximately $482 million in annualized in-force premiums. |
• | Profits followed by losses in our long-term care insurance business. |
• | Mandatory payments of the AXA promissory note |
excluding future claims still being processed. As of September 30, 2021, we owe AXA approximately £24 million ($32 million) for estimated future claims still in process. See note 14 in our unaudited condensed consolidated financial statements for additional information. |
• | Redemption and repurchase of Genworth Holdings’ September 2021 senior notes. pre-tax loss of $4 million. |
• | Redemption of Genworth Holdings’ February 2021 senior notes. |
• | Liquidity and contractual obligations |
• | Completion of minority IPO of Enact Holdings. |
• | Sale of our Australian mortgage insurance business. |
Three months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 944 | $ | 963 | $ | (19 | ) | (2 | )% | |||||||
Net investment income |
859 | 820 | 39 | 5 | % | |||||||||||
Net investment gains (losses) |
88 | 351 | (263 | ) | (75 | )% | ||||||||||
Policy fees and other income |
179 | 184 | (5 | ) | (3 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
2,070 | 2,318 | (248 | ) | (11 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
1,143 | 1,273 | (130 | ) | (10 | )% | ||||||||||
Interest credited |
123 | 137 | (14 | ) | (10 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
290 | 235 | 55 | 23 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
106 | 94 | 12 | 13 | % | |||||||||||
Interest expense |
35 | 47 | (12 | ) | (26 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
1,697 | 1,786 | (89 | ) | (5 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
373 | 532 | (159 | ) | (30 | )% | ||||||||||
Provision for income taxes |
67 | 130 | (63 | ) | (48 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
306 | 402 | (96 | ) | (24 | )% | ||||||||||
Income from discontinued operations, net of taxes |
12 | 34 | (22 | ) | (65 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income |
318 | 436 | (118 | ) | (27 | )% | ||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
4 | — | 4 | NM | (1) | |||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— | 18 | (18 | ) | (100 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 314 | $ | 418 | $ | (104 | ) | (25 | )% | |||||||
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | 302 | $ | 402 | $ | (100 | ) | (25 | )% | |||||||
Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
12 | 16 | (4 | ) | (25 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 314 | $ | 418 | $ | (104 | ) | (25 | )% | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
• | Our U.S. Life Insurance segment decreased $12 million. Our long-term care insurance business decreased $9 million primarily driven by policy terminations and policies entering paid-up status, partially offset by $24 million of increased premiums in the current year from in-force rate actions approved and implemented. Our life insurance business decreased $3 million mainly attributable to the continued runoff of our term and whole life insurance products in the current year. |
• | Our Enact segment decreased $8 million mainly due to lower policy cancellations in our single premium mortgage insurance product, continued lapse of our older higher priced policies due to the |
current low interest rate environment and higher ceded premiums, partially offset by higher insurance in-force in the current year. |
• | Our U.S. Life Insurance segment decreased $124 million. Our long-term care insurance business decreased $99 million primarily due to a more favorable impact of $120 million from reduced benefits in the current year related to in-force rate actions approved and implemented, which included policyholder benefit reduction elections made as part of a legal settlement, and from favorable development on IBNR claims. These decreases were partially offset by aging of the in-force block, a decrease in claim terminations driven mostly by lower mortality in the current year and higher incremental reserves of $53 million recorded in connection with an accrual for profits followed by losses in the current year. In the prior year we assumed that COVID-19 temporarily decreased the number of new submitted claims and accordingly IBNR reserves were strengthened by $24 million. In the third quarter of 2021, as new submitted claims increased, we reduced IBNR reserves by $22 million. Our life insurance business decreased $17 million primarily attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance block which entered its post-level premium period, partially offset by higher mortality in our term universal and term life insurance products in the current year compared to the prior year. Our fixed annuities business decreased $8 million principally from lower reserves in our fixed indexed annuity products driven by favorable interest rate changes and equity market performance and from lower interest credited due to block runoff, partially offset by lower mortality in our single premium immediate annuities in the current year. |
• | Our Enact segment decreased $11 million largely from lower new delinquencies in the current year, partially offset by lower reserves of $23 million from favorable development on IBNR delinquencies in the prior year that did not recur. New delinquencies were higher in the prior year driven primarily by an increase in borrower forbearance as a result of COVID-19. |
• | Our Runoff segment increased $5 million primarily attributable to higher mortality in our corporate-owned life insurance products in the current year. |
• | Our U.S. Life Insurance segment decreased $10 million primarily related to our life insurance and fixed annuities businesses, which decreased $4 million and $6 million, respectively. The decrease was largely driven by a decline in the average account values from block runoff and from lower crediting rates in the current year. |
• | Our Runoff segment decreased $4 million largely due to our corporate-owned life insurance products in the current year. |
• | Our U.S. Life Insurance segment increased $9 million. Our long-term care insurance business increased $6 million principally from policy terminations and policies entering paid-up status in the current year. Our life insurance business increased $7 million primarily driven by a DAC impairment of $38 million in our term universal life insurance product, partially offset by higher prior year lapses in our large 20-year term life insurance block written in 2000. |
• | Our Runoff segment increased $3 million primarily from higher DAC amortization in our variable annuity products due to unfavorable equity market performance in the current year. |
• | Corporate and Other activities decreased $19 million largely driven by the redemption of Genworth Holdings’ senior notes due in February 2021 and September 2021. |
• | Our Enact segment increased $7 million related to Enact Holdings’ senior notes issued in August 2020. |
Nine months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 2,859 | $ | 2,866 | $ | (7 | ) | — | % | |||||||
Net investment income |
2,504 | 2,381 | 123 | 5 | % | |||||||||||
Net investment gains (losses) |
191 | 345 | (154 | ) | (45 | )% | ||||||||||
Policy fees and other income |
542 | 538 | 4 | 1 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
6,096 | 6,130 | (34 | ) | (1 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
3,522 | 4,057 | (535 | ) | (13 | )% | ||||||||||
Interest credited |
381 | 417 | (36 | ) | (9 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
869 | 682 | 187 | 27 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
269 | 289 | (20 | ) | (7 | )% | ||||||||||
Interest expense |
129 | 140 | (11 | ) | (8 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
5,170 | 5,585 | (415 | ) | (7 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
926 | 545 | 381 | 70 | % | |||||||||||
Provision for income taxes |
201 | 148 | 53 | 36 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
725 | 397 | 328 | 83 | % | |||||||||||
Income (loss) from discontinued operations, net of taxes |
28 | (451 | ) | 479 | 106 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income (loss) |
753 | (54 | ) | 807 | NM | (1) | ||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
4 | — | 4 | NM | (1) | |||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
8 | 35 | (27 | ) | (77 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 741 | $ | (89 | ) | $ | 830 | NM | (1) | |||||||
|
|
|
|
|
|
|||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | 721 | $ | 397 | $ | 324 | 82 | % | ||||||||
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
20 | (486 | ) | 506 | 104 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 741 | $ | (89 | ) | $ | 830 | NM | (1) | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
• | Our U.S. Life Insurance segment decreased $25 million. Our long-term care insurance business decreased $6 million primarily driven by policy terminations and policies entering paid-up status in the current year, partially offset by $71 million of increased premiums in the current year from in-force rate actions approved and implemented. Our life insurance business decreased $19 million mainly attributable to the continued runoff of our term and whole life insurance products in the current year. |
• | Our Enact segment increased $18 million mainly attributable to higher insurance in-force, partially offset by continued lapse of our older higher priced policies due to the current low interest rate environment, higher ceded premiums and lower policy cancellations in our single premium mortgage insurance product in the current year. |
• | Our U.S. Life Insurance segment decreased $350 million. Our long-term care insurance business decreased $252 million primarily due to a more favorable impact of $267 million from reduced benefits in the current year related to in-force rate actions approved and implemented, which included policyholder benefit reduction elections made as part of a legal settlement, and from favorable development on IBNR claims. Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, IBNR reserves were strengthened by $61 million in the prior year and by $10 million in the current year, partially offsetting the favorable development on IBNR claims in each year. These decreases were partially offset by aging of the in-force block and higher incremental reserves of $248 million recorded in connection with an accrual for profits followed by losses in the current year. In addition, we increased claim reserves by $51 million reflecting our assumption that COVID-19 accelerated our mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our life insurance business decreased $81 million primarily attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance block which entered its post-level premium period, partially offset by higher mortality in our universal and term universal life insurance products in the current year compared to the prior year. Our fixed annuities business decreased $17 million principally from lower reserves in our fixed indexed annuities driven by favorable interest rate and equity market changes in the current year compared to an unfavorable market in the prior year. |
• | Our Enact segment decreased $173 million largely from lower new delinquencies and lower unfavorable reserve adjustments in the current year. Losses from new delinquencies decreased $151 million compared to the prior year driven primarily by a significant increase in borrower forbearance in the prior year as a result of COVID-19. We strengthened reserves by $10 million in the current year primarily due to our expectation that pre-COVID-19 |
• | Our Runoff segment decreased $9 million primarily attributable to lower guaranteed minimum death benefit (“GMDB”) reserves in our variable annuity products due to favorable equity market and interest rate performance, partially offset by higher mortality in our corporate-owned life insurance products in the current year. |
• | Our U.S. Life Insurance segment decreased $30 million primarily related to our life insurance and fixed annuities businesses, which decreased $11 million and $19 million, respectively. The decrease was largely driven by a decline in the average account values from block runoff and from lower crediting rates in the current year. |
• | Our Runoff segment decreased $6 million largely due to our corporate-owned life insurance products in the current year. |
• | Our U.S. Life Insurance segment increased $166 million predominantly related to our long-term care insurance business principally related to higher premium taxes, commissions and other expenses of $159 million associated with our in-force rate action plan, which included expenses related to policyholder benefit reduction elections made as part of a legal settlement in the current year. |
• | Our Enact segment increased $24 million primarily attributable to higher operating costs, expenses associated with strategic transaction preparations and restructuring costs in the current year. |
• | Our Runoff segment increased $3 million mainly from higher commissions in our variable annuity products in the current year. |
• | Corporate and Other activities decreased $6 million mainly driven by lower operating costs and from a lower make-whole premium in the current year related to the early redemption of Genworth Holdings’ senior notes, partially offset by restructuring costs of $9 million and a $4 million loss in the current year related to the repurchase of Genworth Holdings’ senior notes compared to a $4 million gain in the prior year. |
• | Our U.S. Life Insurance segment decreased $16 million. Our long-term care insurance business increased $12 million principally from policy terminations and policies entering paid-up status in the current year. Our life insurance business decreased $6 million principally from higher prior year lapses in our large 20-year term life insurance block written in 2000, partially offset by DAC impairments of $76 million in our universal and term universal life insurance products in the current year. Our fixed annuities business decreased $22 million primarily related to lower DAC amortization reflecting the impact of favorable market changes in the current year. |
• | Our Runoff segment decreased $4 million mainly related to lower DAC amortization in our variable annuity products principally from favorable equity market performance in the current year. |
• | Corporate and Other activities decreased $38 million largely driven by the redemption of Genworth Holdings’ senior notes due in February 2021 and September 2021 and from the early redemption of Genworth Holdings’ senior notes in the prior year originally scheduled to mature in June 2020. |
• | Our U.S. Life Insurance segment decreased $5 million due to our life insurance business principally related to the early redemption of non-recourse funding obligations in the prior year. |
• | Our Enact segment increased $32 million related to Enact Holdings’ senior notes issued in August 2020. |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 314 | $ | 418 | $ | 741 | $ | (89 | ) | |||||||
Add: net income from continuing operations attributable to noncontrolling interests |
4 | — | 4 | — | ||||||||||||
Add: net income from discontinued operations attributable to noncontrolling interests |
— | 18 | 8 | 35 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
318 | 436 | 753 | (54 | ) | |||||||||||
Less: income (loss) from discontinued operations, net of taxes |
12 | 34 | 28 | (451 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from continuing operations |
306 | 402 | 725 | 397 | ||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
4 | — | 4 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
302 | 402 | 721 | 397 | ||||||||||||
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Net investment (gains) losses, net (1) |
(88 | ) | (350 | ) | (191 | ) | (359 | ) | ||||||||
(Gains) losses on early extinguishment of debt, net |
6 | — | 10 | 9 | ||||||||||||
Expenses related to restructuring |
3 | — | 29 | 2 | ||||||||||||
Taxes on adjustments |
16 | 73 | 32 | 73 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 239 | $ | 125 | $ | 601 | $ | 122 | ||||||||
|
|
|
|
|
|
|
|
(1) |
For the three and nine months ended September 30, 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $1 million and $(14) million, respectively. |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions, except per share amounts) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
Basic |
$ | 0.59 | $ | 0.79 | $ | 1.42 | $ | 0.78 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
$ | 0.59 | $ | 0.79 | $ | 1.40 | $ | 0.78 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
Basic |
$ | 0.62 | $ | 0.83 | $ | 1.46 | $ | (0.18 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
$ | 0.61 | $ | 0.82 | $ | 1.44 | $ | (0.17 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
Basic |
$ | 0.47 | $ | 0.25 | $ | 1.19 | $ | 0.24 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
$ | 0.46 | $ | 0.25 | $ | 1.17 | $ | 0.24 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted-average common shares outstanding: |
||||||||||||||||
Basic |
507.4 | 505.6 | 506.8 | 505.1 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
514.2 | 511.5 | 514.4 | 511.2 | ||||||||||||
|
|
|
|
|
|
|
|
• | GMICO to maintain 115% of PMIERs minimum required assets through 2021, 120% during 2022 and 125% thereafter; |
• | Enact Holdings to retain $300 million of its holding company cash that can be drawn down exclusively for its debt service or to contribute to GMICO to meet their regulatory capital needs including PMIERs; and |
• | written approval must be received from the GSEs prior to any additional debt issuance by either GMICO or Enact Holdings. |
Three months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 243 | $ | 251 | $ | (8 | ) | (3 | )% | |||||||
Net investment income |
36 | 34 | 2 | 6 | % | |||||||||||
Net investment gains (losses) |
1 | (2 | ) | 3 | 150 | % | ||||||||||
Policy fees and other income |
1 | 1 | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
281 | 284 | (3 | ) | (1 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
34 | 45 | (11 | ) | (24 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
55 | 54 | 1 | 2 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
3 | 3 | — | — | % | |||||||||||
Interest expense |
13 | 6 | 7 | 117 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
105 | 108 | (3 | ) | (3 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
176 | 176 | — | — | % | |||||||||||
Provision for income taxes |
38 | 37 | 1 | 3 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
138 | 139 | (1 | ) | (1 | )% | ||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
4 | — | 4 | NM | (1) | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
134 | 139 | (5 | ) | (4 | )% | ||||||||||
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Net investment (gains) losses |
(1 | ) | 2 | (3 | ) | (150 | )% | |||||||||
Expenses related to restructuring |
1 | — | 1 | NM | (1) | |||||||||||
Taxes on adjustments |
— | — | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 134 | $ | 141 | $ | (7 | ) | (5 | )% | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
Nine months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 738 | $ | 720 | $ | 18 | 3 | % | ||||||||
Net investment income |
106 | 98 | 8 | 8 | % | |||||||||||
Net investment gains (losses) |
(2 | ) | (3 | ) | 1 | 33 | % | |||||||||
Policy fees and other income |
3 | 4 | (1 | ) | (25 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
845 | 819 | 26 | 3 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
119 | 292 | (173 | ) | (59 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
175 | 151 | 24 | 16 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
11 | 11 | — | — | % | |||||||||||
Interest expense |
38 | 6 | 32 | NM | (1) | |||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
343 | 460 | (117 | ) | (25 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
502 | 359 | 143 | 40 | % | |||||||||||
Provision for income taxes |
107 | 76 | 31 | 41 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
395 | 283 | 112 | 40 | % | |||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
4 | — | 4 | NM | (1) | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
391 | 283 | 108 | 38 | % | |||||||||||
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Net investment (gains) losses |
2 | 3 | (1 | ) | (33 | )% | ||||||||||
Expenses related to restructuring |
3 | — | 3 | NM | (1) | |||||||||||
Taxes on adjustments |
(1 | ) | — | (1 | ) | NM | (1) | |||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 395 | $ | 286 | $ | 109 | 38 | % | ||||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
As of September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Primary insurance in-force (1) |
$ | 222,500 | $ | 203,100 | $ | 19,400 | 10 | % | ||||||||
Risk in-force: |
||||||||||||||||
Primary |
$ | 55,900 | $ | 51,400 | $ | 4,500 | 9 | % | ||||||||
Pool |
100 | 100 | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total risk in-force |
$ | 56,000 | $ | 51,500 | $ | 4,500 | 9 | % | ||||||||
|
|
|
|
|
|
(1) |
Primary insurance in-force represents the aggregate unpaid principal balance for loans we insure. Original loan balances are primarily used to determine premiums. |
Three months ended September 30, |
Increase (decrease) and percentage change |
Nine months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
2021 |
2020 |
2021 vs. 2020 |
||||||||||||||||||||||||||
New insurance written |
$ | 24,000 | $ | 26,600 | $ | (2,600 | ) | (10 | )% | $ | 75,600 | $ | 72,900 | $ | 2,700 | 4 | % |
Three months ended September 30, |
Increase (decrease) |
Nine months ended September 30, |
Increase (decrease) |
|||||||||||||||||||||
2021 |
2020 |
2021 vs. 2020 |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||||||||
Loss ratio |
14 | % | 18 | % | (4 | )% | 16 | % | 41 | % | (25 | )% | ||||||||||||
Expense ratio (net earned premiums) |
24 | % | 23 | % | 1 | % | 25 | % | 23 | % | 2 | % |
(Amounts in millions) |
2021 |
2020 |
||||||
Primary insurance in-force by loan-to-value |
||||||||
95.01% and above |
$ | 34,259 | $ | 34,563 | ||||
90.01% to 95.00% |
94,888 | 91,478 | ||||||
85.01% to 90.00% |
63,349 | 54,787 | ||||||
85.00% and below |
29,968 | 22,234 | ||||||
|
|
|
|
|||||
Total |
$ | 222,464 | $ | 203,062 | ||||
|
|
|
|
|||||
Primary risk in-force by loan-to-value |
||||||||
95.01% and above |
$ | 9,490 | $ | 9,196 | ||||
90.01% to 95.00% |
27,509 | 26,403 | ||||||
85.01% to 90.00% |
15,322 | 13,188 | ||||||
85.00% and below |
3,545 | 2,606 | ||||||
|
|
|
|
|||||
Total |
$ | 55,866 | $ | 51,393 | ||||
|
|
|
|
|||||
Primary insurance in-force by FICO(1) score at origination: |
||||||||
Over 760 |
$ | 87,073 | $ | 77,557 | ||||
740-759 |
35,177 | 33,208 | ||||||
720-739 |
31,374 | 29,277 | ||||||
700-719 |
27,371 | 24,723 | ||||||
680-699 |
21,458 | 19,129 | ||||||
660-679 (2) |
10,309 | 9,387 | ||||||
640-659 |
6,009 | 5,756 | ||||||
620-639 |
2,787 | 2,861 | ||||||
<620 |
906 | 1,164 | ||||||
|
|
|
|
|||||
Total |
$ | 222,464 | $ | 203,062 | ||||
|
|
|
|
|||||
Primary risk in-force by FICO score at origination: |
||||||||
Over 760 |
$ | 21,767 | $ | 19,549 | ||||
740-759 |
8,824 | 8,424 | ||||||
720-739 |
7,966 | 7,489 | ||||||
700-719 |
6,923 | 6,288 | ||||||
680-699 |
5,383 | 4,864 | ||||||
660-679 (2) |
2,568 | 2,331 | ||||||
640-659 |
1,497 | 1,423 | ||||||
620-639 |
705 | 725 | ||||||
<620 |
233 | 300 | ||||||
|
|
|
|
|||||
Total |
$ | 55,866 | $ | 51,393 | ||||
|
|
|
|
(1) |
Fair Isaac Company. |
(2) |
Loans with unknown FICO scores are included in the 660-679 category. |
September 30, 2021 |
December 31, 2020 |
September 30, 2020 |
||||||||||
Primary insurance: |
||||||||||||
Insured loans in-force |
936,934 | 924,624 | 913,974 | |||||||||
Delinquent loans |
28,904 | 44,904 | 49,692 | |||||||||
Percentage of delinquent loans (delinquency rate) |
3.08 | % | 4.86 | % | 5.44 | % |
September 30, 2021 |
||||||||||||||||
(Dollar amounts in millions) |
Delinquencies |
Direct case reserves (1) |
Risk in-force |
Reserves as % of risk in-force |
||||||||||||
Payments in default: |
||||||||||||||||
3 payments or less |
6,192 | $ | 32 | $ | 320 | 10 | % | |||||||||
4 - 11 payments |
9,021 | 128 | 528 | 24 | % | |||||||||||
12 payments or more |
13,691 | 453 | 813 | 56 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
28,904 | $ | 613 | $ | 1,661 | 37 | % | |||||||||
|
|
|
|
|
|
December 31, 2020 |
||||||||||||||||
(Dollar amounts in millions) |
Delinquencies |
Direct case reserves (1) |
Risk in-force |
Reserves as % of risk in-force |
||||||||||||
Payments in default: |
||||||||||||||||
3 payments or less |
10,484 | $ | 43 | $ | 549 | 8 | % | |||||||||
4 - 11 payments |
30,324 | 331 | 1,853 | 18 | % | |||||||||||
12 payments or more |
4,096 | 143 | 204 | 70 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
44,904 | $ | 517 | $ | 2,606 | 20 | % | |||||||||
|
|
|
|
|
|
(1) |
Direct primary case reserves exclude loss adjustment expenses, IBNR and reinsurance reserves. |
Percent of primary risk in-force as ofSeptember 30, 2021 |
Percent of direct case reserves as of September 30, 2021 (1) |
Delinquency rate as of |
||||||||||||||||||
September 30, 2021 |
December 31, 2020 |
September 30, 2020 |
||||||||||||||||||
By State: |
||||||||||||||||||||
California |
11 | % | 11 | % | 3.91 | % | 6.20 | % | 7.13 | % | ||||||||||
Texas |
8 | % | 8 | % | 3.47 | % | 5.82 | % | 6.57 | % | ||||||||||
Florida (2) |
7 | % | 9 | % | 3.73 | % | 6.92 | % | 8.04 | % | ||||||||||
New York (2) |
5 | % | 12 | % | 4.41 | % | 6.92 | % | 7.78 | % | ||||||||||
Illinois (2) |
5 | % | 6 | % | 3.53 | % | 5.21 | % | 5.90 | % | ||||||||||
Michigan |
4 | % | 2 | % | 2.01 | % | 2.93 | % | 3.53 | % | ||||||||||
Arizona |
3 | % | 2 | % | 2.64 | % | 4.54 | % | 5.01 | % | ||||||||||
North Carolina |
3 | % | 2 | % | 2.54 | % | 3.84 | % | 4.47 | % | ||||||||||
Pennsylvania (2) |
3 | % | 3 | % | 2.75 | % | 4.11 | % | 4.52 | % | ||||||||||
Washington |
3 | % | 3 | % | 3.65 | % | 5.37 | % | 5.60 | % |
(1) |
Direct primary case reserves exclude loss adjustment expenses, IBNR and reinsurance reserves. |
(2) |
Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be complete. |
Percent of primary risk in-force as ofSeptember 30, 2021 |
Percent of direct case reserves as of September 30, 2021 (1) |
Delinquency rate as of |
||||||||||||||||||
September 30, 2021 |
December 31, 2020 |
September 30, 2020 |
||||||||||||||||||
By MSA or MD: |
||||||||||||||||||||
Chicago-Naperville MD |
3 | % | 4 | % | 4.38 | % | 6.36 | % | 7.30 | % | ||||||||||
Phoenix MSA |
3 | % | 2 | % | 2.64 | % | 4.63 | % | 5.09 | % | ||||||||||
New York MD |
3 | % | 8 | % | 6.48 | % | 10.25 | % | 11.37 | % | ||||||||||
Atlanta MSA |
2 | % | 3 | % | 4.00 | % | 6.68 | % | 7.57 | % | ||||||||||
Washington DC-Arlington MD |
2 | % | 2 | % | 3.88 | % | 6.09 | % | 7.06 | % | ||||||||||
Houston MSA |
2 | % | 3 | % | 4.51 | % | 7.59 | % | 8.25 | % | ||||||||||
Riverside-San Bernardino MSA |
2 | % | 2 | % | 4.42 | % | 7.08 | % | 8.08 | % | ||||||||||
Los Angeles-Long Beach MD |
2 | % | 3 | % | 4.98 | % | 7.57 | % | 8.88 | % | ||||||||||
Dallas MD |
2 | % | 2 | % | 3.02 | % | 5.10 | % | 6.14 | % | ||||||||||
Nassau-Suffolk MD |
2 | % | 4 | % | 6.93 | % | 10.64 | % | 11.66 | % |
(1) |
Direct primary case reserves exclude loss adjustment expenses, IBNR and reinsurance reserves. |
(Amounts in millions) |
Weighted average rate (1) |
Percent of direct case reserves (2) |
Primary insurance in-force |
Percent of total |
Primary risk in-force |
Percent of total |
Delinquency rate |
|||||||||||||||||||||
Policy Year |
|
|||||||||||||||||||||||||||
2004 and prior |
6.19 | % | 3 | % | $ | 583 | — | % | $ | 167 | — | % | 14.96 | % | ||||||||||||||
2005 to 2008 |
5.57 | % | 24 | 8,380 | 4 | 2,142 | 4 | 11.14 | % | |||||||||||||||||||
2009 to 2013 |
4.28 | % | 3 | 1,656 | 1 | 441 | 1 | 6.03 | % | |||||||||||||||||||
2014 |
4.49 | % | 3 | 2,293 | 1 | 621 | 1 | 5.81 | % | |||||||||||||||||||
2015 |
4.17 | % | 5 | 5,087 | 2 | 1,355 | 2 | 4.67 | % | |||||||||||||||||||
2016 |
3.89 | % | 8 | 10,082 | 4 | 2,676 | 5 | 4.31 | % | |||||||||||||||||||
2017 |
4.26 | % | 10 | 10,185 | 5 | 2,631 | 5 | 5.31 | % | |||||||||||||||||||
2018 |
4.78 | % | 13 | 10,568 | 5 | 2,656 | 5 | 6.51 | % | |||||||||||||||||||
2019 |
4.20 | % | 18 | 24,884 | 11 | 6,239 | 11 | 4.43 | % | |||||||||||||||||||
2020 |
3.24 | % | 12 | 75,785 | 34 | 18,965 | 34 | 1.43 | % | |||||||||||||||||||
2021 |
3.04 | % | 1 | 72,961 | 33 | 17,973 | 32 | 0.24 | % | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total portfolio |
3.57 | % | 100 | % | $ | 222,464 | 100 | % | $ | 55,866 | 100 | % | 3.08 | % | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Average annual mortgage interest rate weighted by insurance in-force. |
(2) |
Direct primary case reserves exclude loss adjustment expenses, IBNR and reinsurance reserves. |
Three months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 699 | $ | 711 | $ | (12 | ) | (2 | )% | |||||||
Net investment income |
773 | 726 | 47 | 6 | % | |||||||||||
Net investment gains (losses) |
87 | 348 | (261 | ) | (75 | )% | ||||||||||
Policy fees and other income |
144 | 152 | (8 | ) | (5 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
1,703 | 1,937 | (234 | ) | (12 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
1,097 | 1,221 | (124 | ) | (10 | )% | ||||||||||
Interest credited |
85 | 95 | (10 | ) | (11 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
211 | 158 | 53 | 34 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
96 | 87 | 9 | 10 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
1,489 | 1,561 | (72 | ) | (5 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
214 | 376 | (162 | ) | (43 | )% | ||||||||||
Provision for income taxes |
53 | 87 | (34 | ) | (39 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
161 | 289 | (128 | ) | (44 | )% | ||||||||||
Adjustments to income from continuing operations: |
||||||||||||||||
Net investment (gains) losses, net |
(87 | ) | (348 | ) | 261 | 75 | % | |||||||||
Expenses related to restructuring |
1 | — | 1 | NM | (1) | |||||||||||
Taxes on adjustments |
18 | 73 | (55 | ) | (75 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 93 | $ | 14 | $ | 79 | NM | (1) | ||||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
Three months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Long-term care insurance |
$ | 133 | $ | 59 | $ | 74 | 125 | % | ||||||||
Life insurance |
(68 | ) | (69 | ) | 1 | 1 | % | |||||||||
Fixed annuities |
28 | 24 | 4 | 17 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 93 | $ | 14 | $ | 79 | NM | (1) | ||||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
• | Adjusted operating income available to Genworth Financial, Inc.’s common stockholders in our long-term care insurance business increased $74 million primarily from higher premiums and reduced benefits of $66 million in the current year from in-force rate actions approved and implemented, which included a net favorable impact from policyholder benefit reduction elections made as part of a legal settlement in the current year. The increase was also attributable to higher net investment income and favorable development on IBNR claims, partially offset by a decrease in claim terminations driven mostly by lower mortality in the current year. |
• | The adjusted operating loss available to Genworth Financial, Inc.’s common stockholders in our life insurance business decreased $1 million mainly attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance blocks entering its post-level premium period and from lower lapses primarily associated with our large 20-year term life insurance block written at the end of 2000 as it entered its post-level premium period. These improvements were partially offset by a DAC impairment of $30 million in our term universal life insurance product and higher mortality in our term universal and term life insurance products in the current year. |
• | Adjusted operating income available to Genworth Financial, Inc.’s common stockholders in our fixed annuities business increased $4 million mainly attributable to lower reserves in our fixed indexed annuities driven by favorable changes in interest rates and equity markets in the current year, partially offset by lower mortality in our single premium immediate annuities and lower net spreads in the current year. |
• | Our long-term care insurance business decreased $9 million primarily driven by policy terminations and policies entering paid-up status, partially offset by $24 million of increased premiums in the current year from in-force rate actions approved and implemented. |
• | Our life insurance business decreased $3 million mainly attributable to the continued runoff of our term and whole life insurance products in the current year. |
• | Our long-term care insurance business increased $65 million largely from higher income of $57 million in the current year mostly from limited partnerships, U.S. Government Treasury Inflation Protected Securities (“TIPS”) and bond calls. The increase was also attributable to higher average invested assets in the current year. |
• | Our fixed annuities business decreased $15 million largely attributable to lower average invested assets in the current year due to block runoff. |
• | Net investment gains in our long-term care insurance business decreased $267 million principally due to net gains from the sale of U.S. government securities in the prior year due to portfolio rebalancing and asset exposure management that did not recur, partially offset by higher unrealized gains from changes in the fair value of equity securities in the current year. |
• | The change to net investments gains of $1 million in the current year from net investment losses of $3 million in the prior year in our fixed annuities business was primarily related to an impairment in the prior year that did not recur and a favorable adjustment to credit losses in the current year. |
• | Our long-term care insurance business decreased $99 million primarily due to a more favorable impact of $120 million from reduced benefits in the current year related to in-force rate actions approved and implemented, which included policyholder benefit reduction elections made as part of a legal settlement, and from favorable development on IBNR claims. These decreases were partially offset by aging of the in-force block, a decrease in claim terminations driven mostly by lower mortality in the current year and higher incremental reserves of $53 million recorded in connection with an accrual for profits followed by losses in the current year. In the prior year we assumed that COVID-19 temporarily decreased the number of new submitted claims and accordingly IBNR reserves were strengthened by $24 million. In the third quarter of 2021, as new submitted claims increased, we reduced IBNR reserves by $22 million. |
• | Our life insurance business decreased $17 million primarily attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance block which entered its post-level premium period, partially offset by higher mortality in our term universal and term life insurance products in the current year compared to the prior year. |
• | Our fixed annuities business decreased $8 million principally from lower reserves in our fixed indexed annuity products driven by favorable interest rate changes and equity market performance and from lower interest credited due to block runoff, partially offset by lower mortality in our single premium immediate annuities in the current year. |
• | Our long-term care insurance business increased $6 million principally from policy terminations and policies entering paid-up status in the current year. |
• | Our life insurance business increased $7 million primarily driven by a DAC impairment of $38 million in our term universal life insurance product, partially offset by higher prior year lapses in our large 20-year term life insurance block written in 2000. |
Nine months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 2,116 | $ | 2,141 | $ | (25 | ) | (1 | )% | |||||||
Net investment income |
2,252 | 2,113 | 139 | 7 | % | |||||||||||
Net investment gains (losses) |
195 | 396 | (201 | ) | (51 | )% | ||||||||||
Policy fees and other income |
437 | 438 | (1 | ) | — | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
5,000 | 5,088 | (88 | ) | (2 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
3,381 | 3,731 | (350 | ) | (9 | )% | ||||||||||
Interest credited |
262 | 292 | (30 | ) | (10 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
622 | 456 | 166 | 36 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
241 | 257 | (16 | ) | (6 | )% | ||||||||||
Interest expense |
— | 5 | (5 | ) | (100 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
4,506 | 4,741 | (235 | ) | (5 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
494 | 347 | 147 | 42 | % | |||||||||||
Provision for income taxes |
127 | 93 | 34 | 37 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
367 | 254 | 113 | 44 | % | |||||||||||
Adjustments to income from continuing operations: |
||||||||||||||||
Net investment (gains) losses, net (2) |
(195 | ) | (402 | ) | 207 | 51 | % | |||||||||
(Gains) losses on early extinguishment of debt |
— | 4 | (4 | ) | (100 | )% | ||||||||||
Expenses related to restructuring |
17 | — | 17 | NM | (1) | |||||||||||
Taxes on adjustments |
37 | 83 | (46 | ) | (55 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 226 | $ | (61 | ) | $ | 287 | NM | (1) | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
(2) |
For the nine months ended September 30, 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(6) million. |
Nine months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Long-term care insurance |
$ | 326 | $ | 108 | $ | 218 | NM | (1) | ||||||||
Life insurance |
(171 | ) | (227 | ) | 56 | 25 | % | |||||||||
Fixed annuities |
71 | 58 | 13 | 22 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 226 | $ | (61 | ) | $ | 287 | NM | (1) | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
• | Adjusted operating income available to Genworth Financial, Inc.’s common stockholders in our long-term care insurance business increased $218 million primarily from higher net investment income, as well as higher premiums and reduced benefits of $141 million in the current year from in-force rate actions approved and implemented, which included a net favorable impact from policyholder benefit reduction elections made as part of a legal settlement in the current year. The increase was also attributable to favorable development on IBNR claims driven by lower incidence in the current year. |
• | The adjusted operating loss available to Genworth Financial, Inc.’s common stockholders in our life insurance business decreased $56 million mainly attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance block entering its post-level premium period and from lower lapses primarily associated with our large 20-year term life insurance block written at the end of 2000 as it entered its post-level premium period. These improvements were partially offset by higher mortality in our universal and term universal life insurance products and DAC impairments of $60 million in our universal and term universal life insurance products in the current year. |
• | Adjusted operating income available to Genworth Financial, Inc.’s common stockholders in our fixed annuities business increased $13 million mainly attributable to lower reserves and DAC amortization in our fixed indexed annuities driven by favorable changes in interest rates and equity markets in the current year, partially offset by lower mortality in our single premium immediate annuities and lower net spreads in the current year. |
• | Our long-term care insurance business decreased $6 million primarily driven by policy terminations and policies entering paid-up status in the current year, partially offset by $71 million of increased premiums in the current year from in-force rate actions approved and implemented. |
• | Our life insurance business decreased $19 million mainly attributable to the continued runoff of our term and whole life insurance products in the current year. |
• | Our long-term care insurance business increased $198 million largely from higher income of $170 million in the current year mostly from limited partnerships, TIPS and bond calls. The increase was also attributable to higher average invested assets in the current year. |
• | Our life insurance business decreased $9 million principally related to lower yields and unfavorable prepayment speed adjustments on mortgage-backed securities in the current year. |
• | Our fixed annuities business decreased $50 million largely attributable to lower average invested assets in the current year due to block runoff. |
• | Net investment gains in our long-term care insurance business decreased $247 million principally due to net gains from the sale of U.S. government securities in the prior year due to portfolio rebalancing and asset exposure management that did not recur, partially offset by higher unrealized gains in the current year from changes in the fair value of equity securities and by prior year credit losses. |
• | Net investment gains in our life insurance business increased $14 million predominantly from higher derivative gains and unrealized gains from changes in the fair value of equity securities in the current year compared to unrealized losses in the prior year. |
• | Net investment losses in our fixed annuities business decreased $32 million primarily related to lower net derivative losses in the current year. |
• | Our long-term care insurance business decreased $252 million primarily due to a more favorable impact of $267 million from reduced benefits in the current year related to in-force rate actions approved and implemented, which included policyholder benefit reduction elections made as part of a legal settlement, and from favorable development on IBNR claims. Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, IBNR reserves were strengthened by $61 million in the prior year and by $10 million in the current year, partially offsetting the favorable development on IBNR claims in each year. These decreases were partially offset by aging of the in-force block and higher incremental reserves of $248 million recorded in connection with an accrual for profits followed by losses in the current year. In addition, we increased claim reserves by $51 million reflecting our assumption that COVID-19 accelerated our mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. |
• | Our life insurance business decreased $81 million primarily attributable to higher reserves recorded in the prior year on our 10-year term universal life insurance block which entered its post-level premium period, partially offset by higher mortality in our universal and term universal life insurance products in the current year compared to the prior year. |
• | Our fixed annuities business decreased $17 million principally from lower reserves in our fixed indexed annuities driven by favorable interest rate and equity market changes in the current year compared to an unfavorable market in the prior year. |
• | Our long-term care insurance business increased $12 million principally from policy terminations and policies entering paid-up status in the current year. |
• | Our life insurance business decreased $6 million principally from higher prior year lapses in our large 20-year term life insurance block written in 2000, partially offset by DAC impairments of $76 million in our universal and term universal life insurance products in the current year. |
• | Our fixed annuities business decreased $22 million primarily related to lower DAC amortization reflecting the impact of favorable market changes in the current year. |
Three months ended September 30, |
Increase (decrease) and percentage change |
Nine months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
2021 |
2020 |
2021 vs. 2020 |
||||||||||||||||||||||||||
Premiums |
$ | 215 | $ | 191 | $ | 24 | 13 | % | $ | 617 | $ | 546 | $ | 71 | 13 | % | ||||||||||||||||
Plus: Benefits and other changes in policy reserves (2) |
246 | 126 | 120 | 95 | % | 672 | 405 | 267 | 66 | % | ||||||||||||||||||||||
Less: Acquisition and operating expenses, net of deferrals (3) |
76 | 16 | 60 | NM | (1) |
204 | 45 | 159 | NM | (1) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Adjusted operating income before taxes |
385 | 301 | 84 | 28 | % | 1,085 | 906 | 179 | 20 | % | ||||||||||||||||||||||
Income taxes |
81 | 63 | 18 | 28 | % | 228 | 190 | 38 | 20 | % | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Adjusted operating income (4) |
$ | 304 | $ | 238 | $ | 66 | 28 | % | $ | 857 | $ | 716 | $ | 141 | 20 | % | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
(2) |
Amounts represent benefit reductions elected by policyholders as an alternative to increased premiums. These amounts reduced benefits and other changes in policy reserves in our long-term care insurance business for the periods indicated. |
(3) |
Amounts include premium taxes, commissions and other expenses associated with our long-term care insurance in-force rate action plan, which included expenses of $57 million and $150 million related to policyholder benefit reduction elections made as part of a legal settlement for the three and nine months ended September 30, 2021, respectively. |
(4) |
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders attributable to in-force rate actions excludes reserve updates resulting from profits followed by losses. |
Three months ended September 30, |
Increase (decrease) and percentage change |
Nine months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
2021 |
2020 |
2021 vs. 2020 |
||||||||||||||||||||||||||
Net earned premiums: |
||||||||||||||||||||||||||||||||
Individual long-term care insurance (1) |
$ | 621 | $ | 630 | $ | (9 | ) | (1 | )% | $ | 1,853 | $ | 1,859 | $ | (6 | ) | — | % | ||||||||||||||
Group long-term care insurance |
31 | 31 | — | — | % | 93 | 93 | — | — | % | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total |
$ | 652 | $ | 661 | $ | (9 | ) | (1 | )% | $ | 1,946 | $ | 1,952 | $ | (6 | ) | — | % | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Loss ratio |
58 | % | 71 | % | (13 | )% | 61 | % | 73 | % | (12 | )% |
(1) |
For the three months ended September 30, 2021 and 2020, amounts include increased premiums of $215 million and $191 million, respectively, from in-force rate actions approved and implemented in the current year. For the nine months ended September 30, 2021 and 2020, amounts include increased premiums of $617 million and $546 million, respectively, from in-force rate actions approved and implemented in the current year. |
Three months ended September 30, |
Increase (decrease) and percentage change |
Nine months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
2021 |
2020 |
2021 vs. 2020 |
||||||||||||||||||||||||||
Term and whole life insurance |
||||||||||||||||||||||||||||||||
Net earned premiums |
$ | 47 | $ | 50 | $ | (3 | ) | (6 | )% | $ | 170 | $ | 189 | $ | (19 | ) | (10 | )% | ||||||||||||||
Term universal life insurance |
||||||||||||||||||||||||||||||||
Net deposits |
49 | 53 | (4 | ) | (8 | )% | 155 | 166 | (11 | ) | (7 | )% | ||||||||||||||||||||
Universal life insurance |
||||||||||||||||||||||||||||||||
Net deposits |
68 | 69 | (1 | ) | (1 | )% | 201 | 205 | (4 | ) | (2 | )% | ||||||||||||||||||||
Total life insurance |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net earned premiums and deposits |
$ | 164 | $ | 172 | $ | (8 | ) | (5 | )% | $ | 526 | $ | 560 | $ | (34 | ) | (6 | )% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, |
Percentage change |
|||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||
Term and whole life insurance |
||||||||||||
Life insurance in-force, net of reinsurance |
$ | 54,414 | $ | 63,668 | (15 | )% | ||||||
Life insurance in-force before reinsurance |
$ | 340,153 | $ | 369,356 | (8 | )% | ||||||
Term universal life insurance |
||||||||||||
Life insurance in-force, net of reinsurance |
$ | 101,415 | $ | 108,911 | (7 | )% | ||||||
Life insurance in-force before reinsurance |
$ | 102,079 | $ | 109,665 | (7 | )% | ||||||
Universal life insurance |
||||||||||||
Life insurance in-force, net of reinsurance |
$ | 31,472 | $ | 32,848 | (4 | )% | ||||||
Life insurance in-force before reinsurance |
$ | 35,653 | $ | 37,307 | (4 | )% | ||||||
Total life insurance |
||||||||||||
Life insurance in-force, net of reinsurance |
$ | 187,301 | $ | 205,427 | (9 | )% | ||||||
Life insurance in-force before reinsurance |
$ | 477,885 | $ | 516,328 | (7 | )% |
As of or for the three months ended September 30, |
As of or for the nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Account value, beginning of period |
$ | 10,913 | $ | 12,256 | $ | 11,815 | $ | 13,023 | ||||||||
Premiums and deposits |
25 | 23 | 63 | 62 | ||||||||||||
Surrenders, benefits and product charges |
(465 | ) | (489 | ) | (1,491 | ) | (1,331 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net flows |
(440 | ) | (466 | ) | (1,428 | ) | (1,269 | ) | ||||||||
Interest credited and investment performance |
82 | 104 | 262 | 299 | ||||||||||||
Effect of accumulated net unrealized investment gains (losses) |
(32 | ) | 75 | (126 | ) | (84 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Account value, end of period |
$ | 10,523 | $ | 11,969 | $ | 10,523 | $ | 11,969 | ||||||||
|
|
|
|
|
|
|
|
Three months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Net investment income |
$ | 49 | $ | 55 | $ | (6 | ) | (11 | )% | |||||||
Net investment gains (losses) |
(1 | ) | 15 | (16 | ) | (107 | )% | |||||||||
Policy fees and other income |
33 | 33 | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
81 | 103 | (22 | ) | (21 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
12 | 7 | 5 | 71 | % | |||||||||||
Interest credited |
38 | 42 | (4 | ) | (10 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
12 | 12 | — | — | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
7 | 4 | 3 | 75 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
69 | 65 | 4 | 6 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
12 | 38 | (26 | ) | (68 | )% | ||||||||||
Provision for income taxes |
2 | 8 | (6 | ) | (75 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
10 | 30 | (20 | ) | (67 | )% | ||||||||||
Adjustments to income from continuing operations: |
||||||||||||||||
Net investment (gains) losses, net (1) |
1 | (14 | ) | 15 | 107 | % | ||||||||||
Taxes on adjustments |
— | 3 | (3 | ) | (100 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 11 | $ | 19 | $ | (8 | ) | (42 | )% | |||||||
|
|
|
|
|
|
(1) |
For the three months ended September 30, 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $1 million. |
Nine months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Net investment income |
$ | 141 | $ | 158 | $ | (17 | ) | (11 | )% | |||||||
Net investment gains (losses) |
3 | (56 | ) | 59 | 105 | % | ||||||||||
Policy fees and other income |
101 | 98 | 3 | 3 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
245 | 200 | 45 | 23 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
22 | 31 | (9 | ) | (29 | )% | ||||||||||
Interest credited |
119 | 125 | (6 | ) | (5 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
39 | 36 | 3 | 8 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
16 | 20 | (4 | ) | (20 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
196 | 212 | (16 | ) | (8 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes |
49 | (12 | ) | 61 | NM | (1) | ||||||||||
Provision (benefit) for income taxes |
9 | (4 | ) | 13 | NM | (1) | ||||||||||
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations |
40 | (8 | ) | 48 | NM | (1) | ||||||||||
Adjustments to income (loss) from continuing operations: |
||||||||||||||||
Net investment (gains) losses, net (2) |
(3 | ) | 48 | (51 | ) | (106 | )% | |||||||||
Taxes on adjustments |
1 | (10 | ) | 11 | 110 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 38 | $ | 30 | $ | 8 | 27 | % | ||||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
(2) |
For the nine months ended September 30, 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(8) million. |
As of or for the three months ended September 30, |
As of or for the nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Account value, beginning of period |
$ | 4,968 | $ | 4,782 | $ | 5,001 | $ | 5,042 | ||||||||
Deposits |
6 | 4 | 16 | 14 | ||||||||||||
Surrenders, benefits and product charges |
(136 | ) | (126 | ) | (463 | ) | (414 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net flows |
(130 | ) | (122 | ) | (447 | ) | (400 | ) | ||||||||
Interest credited and investment performance |
(31 | ) | 185 | 253 | 203 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Account value, end of period |
$ | 4,807 | $ | 4,845 | $ | 4,807 | $ | 4,845 | ||||||||
|
|
|
|
|
|
|
|
As of or for the three months ended September 30, |
As of or for the nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Funding Agreements |
||||||||||||||||
Account value, beginning of period |
$ | 250 | $ | 353 | $ | 300 | $ | 253 | ||||||||
Deposits |
— | — | — | 150 | ||||||||||||
Surrenders and benefits |
— | (1 | ) | (51 | ) | (53 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net flows |
— | (1 | ) | (51 | ) | 97 | ||||||||||
Interest credited |
— | 1 | 1 | 3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Account value, end of period |
$ | 250 | $ | 353 | $ | 250 | $ | 353 | ||||||||
|
|
|
|
|
|
|
|
Three months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 2 | $ | 1 | $ | 1 | 100 | % | ||||||||
Net investment income |
1 | 5 | (4 | ) | (80 | )% | ||||||||||
Net investment gains (losses) |
1 | (10 | ) | 11 | 110 | % | ||||||||||
Policy fees and other income |
1 | (2 | ) | 3 | 150 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
5 | (6 | ) | 11 | 183 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
— | — | — | — | % | |||||||||||
Acquisition and operating expenses, net of deferrals |
12 | 11 | 1 | 9 | % | |||||||||||
Interest expense |
22 | 41 | (19 | ) | (46 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
34 | 52 | (18 | ) | (35 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Loss from continuing operations before income taxes |
(29 | ) | (58 | ) | 29 | 50 | % | |||||||||
Benefit for income taxes |
(26 | ) | (2 | ) | (24 | ) | NM | (1) | ||||||||
|
|
|
|
|
|
|||||||||||
Loss from continuing operations |
(3 | ) | (56 | ) | 53 | 95 | % | |||||||||
Adjustments to loss from continuing operations: |
||||||||||||||||
Net investment (gains) losses |
(1 | ) | 10 | (11 | ) | (110 | )% | |||||||||
(Gains) losses on early extinguishment of debt |
6 | — | 6 | NM | (1) | |||||||||||
Expenses related to restructuring |
1 | — | 1 | NM | (1) | |||||||||||
Taxes on adjustments |
(2 | ) | (3 | ) | 1 | 33 | % | |||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 1 | $ | (49 | ) | $ | 50 | 102 | % | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
Nine months ended September 30, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 vs. 2020 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 5 | $ | 5 | $ | — | — | % | ||||||||
Net investment income |
5 | 12 | (7 | ) | (58 | )% | ||||||||||
Net investment gains (losses) |
(5 | ) | 8 | (13 | ) | (163 | )% | |||||||||
Policy fees and other income |
1 | (2 | ) | 3 | 150 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
6 | 23 | (17 | ) | (74 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
— | 3 | (3 | ) | (100 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
33 | 39 | (6 | ) | (15 | )% | ||||||||||
Amortization of deferred acquisition costs and intangibles |
1 | 1 | — | — | % | |||||||||||
Interest expense |
91 | 129 | (38 | ) | (29 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
125 | 172 | (47 | ) | (27 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Loss from continuing operations before income taxes |
(119 | ) | (149 | ) | 30 | 20 | % | |||||||||
Benefit for income taxes |
(42 | ) | (17 | ) | (25 | ) | (147 | )% | ||||||||
|
|
|
|
|
|
|||||||||||
Loss from continuing operations |
(77 | ) | (132 | ) | 55 | 42 | % | |||||||||
Adjustments to loss from continuing operations: |
||||||||||||||||
Net investment (gains) losses |
5 | (8 | ) | 13 | 163 | % | ||||||||||
(Gains) losses on early extinguishment of debt |
10 | 5 | 5 | 100 | % | |||||||||||
Expenses related to restructuring |
9 | 2 | 7 | NM | (1) | |||||||||||
Taxes on adjustments |
(5 | ) | — | (5 | ) | NM | (1) | |||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders |
$ | (58 | ) | $ | (133 | ) | $ | 75 | 56 | % | ||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
Three months ended September 30, |
Increase (decrease) |
|||||||||||||||||||||||
2021 |
2020 |
2021 vs. 2020 |
||||||||||||||||||||||
(Amounts in millions) |
Yield |
Amount |
Yield |
Amount |
Yield |
Amount |
||||||||||||||||||
Fixed maturity securities—taxable |
4.6 | % | $ | 614 | 4.7 | % | $ | 625 | (0.1 | )% | $ | (11 | ) | |||||||||||
Fixed maturity securities—non-taxable |
6.3 | % | 2 | 6.2 | % | 2 | 0.1 | % | — | |||||||||||||||
Equity securities |
5.3 | % | 2 | 3.3 | % | 3 | 2.0 | % | (1 | ) | ||||||||||||||
Commercial mortgage loans |
5.4 | % | 93 | 4.8 | % | 82 | 0.6 | % | 11 | |||||||||||||||
Policy loans |
9.1 | % | 47 | 9.4 | % | 51 | (0.3 | )% | (4 | ) | ||||||||||||||
Other invested assets (1) |
27.1 | % | 122 | 26.1 | % | 79 | 1.0 | % | 43 | |||||||||||||||
Cash, cash equivalents, restricted cash and short-term investments |
0.2 | % | 1 | 0.1 | % | 1 | 0.1 | % | — | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Gross investment income before expenses and fees |
5.3 | % | 881 | 5.1 | % | 843 | 0.2 | % | 38 | |||||||||||||||
Expenses and fees |
(0.1 | )% | (22 | ) | (0.2 | )% | (23 | ) | 0.1 | % | 1 | |||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Net investment income |
5.2 | % | $ | 859 | 4.9 | % | $ | 820 | 0.3 | % | $ | 39 | ||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Average invested assets and cash |
$ | 66,230 | $ | 66,415 | $ | (185 | ) | |||||||||||||||||
|
|
|
|
|
|
Nine months ended September 30, |
Increase (decrease) |
|||||||||||||||||||||||
2021 |
2020 |
2021 vs. 2020 |
||||||||||||||||||||||
(Amounts in millions) |
Yield |
Amount |
Yield |
Amount |
Yield |
Amount |
||||||||||||||||||
Fixed maturity securities—taxable |
4.6 | % | $ | 1,821 | 4.7 | % | $ | 1,830 | (0.1 | )% | $ | (9 | ) | |||||||||||
Fixed maturity securities—non-taxable |
5.2 | % | 5 | 4.7 | % | 5 | 0.5 | % | — | |||||||||||||||
Equity securities |
4.0 | % | 7 | 3.5 | % | 7 | 0.5 | % | — | |||||||||||||||
Commercial mortgage loans |
5.4 | % | 274 | 4.8 | % | 251 | 0.6 | % | 23 | |||||||||||||||
Policy loans |
9.0 | % | 137 | 9.4 | % | 149 | (0.4 | )% | (12 | ) | ||||||||||||||
Other invested assets (1) |
26.4 | % | 323 | 22.6 | % | 192 | 3.8 | % | 131 | |||||||||||||||
Cash, cash equivalents, restricted cash and short-term investments |
0.1 | % | 1 | 0.7 | % | 15 | (0.6 | )% | (14 | ) | ||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Gross investment income before expenses and fees |
5.2 | % | 2,568 | 5.0 | % | 2,449 | 0.2 | % | 119 | |||||||||||||||
Expenses and fees |
(0.2 | )% | (64 | ) | (0.2 | )% | (68 | ) | — | % | 4 | |||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Net investment income |
5.0 | % | $ | 2,504 | 4.8 | % | $ | 2,381 | 0.2 | % | $ | 123 | ||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Average invested assets and cash |
$ | 66,231 | $ | 65,843 | $ | 388 | ||||||||||||||||||
|
|
|
|
|
|
(1) |
Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation and includes limited partnership investments, which are primarily equity-based and do not have fixed returns by period. |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
(Amounts in millions) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Available-for-sale |
||||||||||||||||
Realized gains |
$ | 11 | $ | 320 | $ | 23 | $ | 425 | ||||||||
Realized losses |
— | (1 | ) | (7 | ) | (6 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net realized gains (losses) on available-for-sale |
11 | 319 | 16 | 419 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net change in allowance for credit losses on available-for-sale |
— | 2 | (6 | ) | (5 | ) | ||||||||||
Write-down of available-for-sale |
— | (4 | ) | (1 | ) | (4 | ) | |||||||||
Net realized gains (losses) on equity securities sold |
— | (3 | ) | (7 | ) | (3 | ) | |||||||||
Net unrealized gains (losses) on equity securities still held |
(1 | ) | 3 | (3 | ) | (4 | ) | |||||||||
Limited partnerships |
75 | 31 | 177 | 28 | ||||||||||||
Commercial mortgage loans |
3 | (3 | ) | 1 | (2 | ) | ||||||||||
Derivative instruments |
(3 | ) | 9 | 9 | (75 | ) | ||||||||||
Other |
3 | (3 | ) | 5 | (9 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment gains (losses) |
$ | 88 | $ | 351 | $ | 191 | $ | 345 | ||||||||
|
|
|
|
|
|
|
|
• | We recorded net gains related to the sale of fixed maturity securities of $319 million during the three months ended September 30, 2020 driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. |
• | We recorded $44 million of higher net gains on limited partnerships during the three months ended September 30, 2021 primarily driven by higher unrealized gains from favorable performance of private equity investments in the current year. |
• | Net investment losses related to derivatives of $3 million during the three months ended September 30, 2021 were primarily associated with embedded derivatives in our runoff variable annuity and fixed indexed annuity products, partially offset by gains associated with embedded derivatives in our indexed universal life insurance products. |
• | We recorded net gains related to the sale of available-for-sale |
• | We had $149 million of higher net gains on limited partnership investments during the nine months ended September 30, 2021 primarily driven by favorable performance of private equity investments in the current year. |
• | Net investment gains related to derivatives of $9 million during the nine months ended September 30, 2021 were primarily associated with embedded derivatives in our indexed universal life insurance products, partially offset by losses related to derivatives used to protect statutory surplus from equity market fluctuations. |
September 30, 2021 |
December 31, 2020 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Fixed maturity securities, available-for-sale: |
||||||||||||||||
Public |
$ | 43,125 | 58 | % | $ | 44,776 | 58 | % | ||||||||
Private |
18,149 | 24 | 18,719 | 24 | ||||||||||||
Equity securities |
156 | — | 386 | — | ||||||||||||
Commercial mortgage loans, net |
6,886 | 9 | 6,743 | 9 | ||||||||||||
Policy loans |
2,067 | 3 | 1,978 | 3 | ||||||||||||
Other invested assets |
2,335 | 3 | 2,099 | 3 | ||||||||||||
Cash, cash equivalents and restricted cash |
1,937 | 3 | 2,561 | 3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, restricted cash and invested assets |
$ | 74,655 | 100 | % | $ | 77,262 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | 3,384 | $ | 1,117 | $ | (1 | ) | $ | — | $ | 4,500 | |||||||||
State and political subdivisions |
2,946 | 476 | (4 | ) | — | 3,418 | ||||||||||||||
Non-U.S. government |
760 | 85 | (10 | ) | — | 835 | ||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
4,313 | 787 | (8 | ) | — | 5,092 | ||||||||||||||
Energy |
2,644 | 377 | (10 | ) | — | 3,011 | ||||||||||||||
Finance and insurance |
7,977 | 1,065 | (18 | ) | — | 9,024 | ||||||||||||||
Consumer—non-cyclical |
5,176 | 1,047 | (5 | ) | — | 6,218 | ||||||||||||||
Technology and communications |
3,281 | 488 | (12 | ) | — | 3,757 | ||||||||||||||
Industrial |
1,340 | 179 | (1 | ) | — | 1,518 | ||||||||||||||
Capital goods |
2,395 | 428 | (3 | ) | — | 2,820 | ||||||||||||||
Consumer—cyclical |
1,700 | 213 | (5 | ) | — | 1,908 | ||||||||||||||
Transportation |
1,131 | 241 | — | — | 1,372 | |||||||||||||||
Other |
373 | 39 | — | — | 412 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total U.S. corporate |
30,330 | 4,864 | (62 | ) | — | 35,132 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
888 | 69 | (1 | ) | — | 956 | ||||||||||||||
Energy |
1,213 | 203 | — | — | 1,416 | |||||||||||||||
Finance and insurance |
2,147 | 293 | (7 | ) | — | 2,433 | ||||||||||||||
Consumer—non-cyclical |
673 | 84 | (2 | ) | — | 755 | ||||||||||||||
Technology and communications |
1,109 | 172 | (1 | ) | — | 1,280 | ||||||||||||||
Industrial |
974 | 126 | (1 | ) | — | 1,099 | ||||||||||||||
Capital goods |
627 | 66 | (1 | ) | — | 692 | ||||||||||||||
Consumer—cyclical |
326 | 27 | (1 | ) | — | 352 | ||||||||||||||
Transportation |
422 | 68 | — | — | 490 | |||||||||||||||
Other |
1,089 | 181 | (3 | ) | — | 1,267 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total non-U.S. corporate |
9,468 | 1,289 | (17 | ) | — | 10,740 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Residential mortgage-backed |
1,432 | 141 | (1 | ) | — | 1,572 | ||||||||||||||
Commercial mortgage-backed |
2,496 | 176 | (2 | ) | — | 2,670 | ||||||||||||||
Other asset-backed |
2,365 | 43 | (1 | ) | — | 2,407 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total available-for-sale |
$ | 53,181 | $ | 8,191 | $ | (98 | ) | $ | — | $ | 61,274 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | 3,401 | $ | 1,404 | $ | — | $ | — | $ | 4,805 | ||||||||||
State and political subdivisions |
2,622 | 544 | (1 | ) | — | 3,165 | ||||||||||||||
Non-U.S. government |
728 | 130 | (4 | ) | — | 854 | ||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
4,226 | 970 | (2 | ) | — | 5,194 | ||||||||||||||
Energy |
2,532 | 367 | (16 | ) | — | 2,883 | ||||||||||||||
Finance and insurance |
7,798 | 1,306 | (2 | ) | — | 9,102 | ||||||||||||||
Consumer—non-cyclical |
5,115 | 1,323 | (1 | ) | — | 6,437 | ||||||||||||||
Technology and communications |
3,142 | 619 | — | — | 3,761 | |||||||||||||||
Industrial |
1,370 | 232 | — | — | 1,602 | |||||||||||||||
Capital goods |
2,456 | 535 | — | — | 2,991 | |||||||||||||||
Consumer—cyclical |
1,663 | 284 | — | — | 1,947 | |||||||||||||||
Transportation |
1,198 | 304 | (2 | ) | — | 1,500 | ||||||||||||||
Other |
395 | 45 | — | — | 440 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total U.S. corporate |
29,895 | 5,985 | (23 | ) | — | 35,857 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
838 | 84 | — | — | 922 | |||||||||||||||
Energy |
1,172 | 209 | (1 | ) | — | 1,380 | ||||||||||||||
Finance and insurance |
2,130 | 353 | (6 | ) | (1 | ) | 2,476 | |||||||||||||
Consumer—non-cyclical |
662 | 112 | (1 | ) | — | 773 | ||||||||||||||
Technology and communications |
1,062 | 229 | — | — | 1,291 | |||||||||||||||
Industrial |
969 | 159 | — | — | 1,128 | |||||||||||||||
Capital goods |
510 | 67 | (1 | ) | — | 576 | ||||||||||||||
Consumer—cyclical |
331 | 41 | (1 | ) | — | 371 | ||||||||||||||
Transportation |
483 | 88 | (1 | ) | — | 570 | ||||||||||||||
Other |
1,088 | 236 | — | — | 1,324 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total non-U.S. corporate |
9,245 | 1,578 | (11 | ) | (1 | ) | 10,811 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Residential mortgage-backed (1) |
1,698 | 211 | — | — | 1,909 | |||||||||||||||
Commercial mortgage-backed |
2,759 | 231 | (13 | ) | (3 | ) | 2,974 | |||||||||||||
Other asset-backed |
3,069 | 55 | (4 | ) | — | 3,120 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total available-for-sale |
$ | 53,417 | $ | 10,138 | $ | (56 | ) | $ | (4 | ) | $ | 63,495 | ||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Fair value included $8 million collateralized by Alt-A residential mortgage loans. |
September 30, 2021 |
December 31, 2020 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Limited partnerships |
$ | 1,617 | 69 | % | $ | 1,049 | 50 | % | ||||||||
Derivatives |
338 | 14 | 574 | 28 | ||||||||||||
Bank loan investments |
292 | 13 | 344 | 16 | ||||||||||||
Securities lending collateral |
— | — | 67 | 3 | ||||||||||||
Short-term investments |
69 | 3 | 45 | 2 | ||||||||||||
Other investments |
19 | 1 | 20 | 1 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other invested assets |
$ | 2,335 | 100 | % | $ | 2,099 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
(Notional in millions) |
Measurement |
December 31, 2020 |
Additions |
Maturities/ terminations |
September 30, 2021 |
|||||||||||||
Derivatives designated as hedges |
||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||
Interest rate swaps |
Notional | $ | 8,178 | $ | — | $ | (434 | ) | $ | 7,744 | ||||||||
Foreign currency swaps |
Notional | 127 | — | — | 127 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total cash flow hedges |
8,305 | — | (434 | ) | 7,871 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total derivatives designated as hedges |
8,305 | — | (434 | ) | 7,871 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Derivatives not designated as hedges |
||||||||||||||||||
Interest rate swaps |
Notional | 4,674 | — | (4,674 | ) | — | ||||||||||||
Equity index options |
Notional | 2,000 | 922 | (1,285 | ) | 1,637 | ||||||||||||
Financial futures |
Notional | 1,104 | 2,918 | (3,085 | ) | 937 | ||||||||||||
Other foreign currency contracts |
Notional | 1,186 | 24 | (1,111 | ) | 99 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total derivatives not designated as hedges |
8,964 | 3,864 | (10,155 | ) | 2,673 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total derivatives |
$ | 17,269 | $ | 3,864 | $ | (10,589 | ) | $ | 10,544 | |||||||||
|
|
|
|
|
|
|
|
|||||||||||
(Number of policies) |
Measurement |
December 31, 2020 |
Additions |
Maturities/ terminations |
September 30, 2021 |
|||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||
GMWB embedded derivatives |
Policies | 23,713 | — | (1,409 | ) | 22,304 | ||||||||||||
Fixed index annuity embedded derivatives |
Policies | 12,778 | — | (2,660 | ) | 10,118 | ||||||||||||
Indexed universal life embedded derivatives |
Policies | 842 | — | (36 | ) | 806 |
• | Cash, cash equivalents, restricted cash and invested assets decreased $2,607 million primarily from decreases of $2,221 million, $624 million and $230 million in fixed maturity securities, cash, cash equivalents, restricted cash and equity securities, respectively. The decrease in fixed maturity securities was predominantly related to a decrease in unrealized gains due to an increase in interest rates and from net sales in the current year. The decrease in cash, cash equivalents and restricted cash was largely related to net withdrawals from our investment contracts, the redemption of Genworth Holdings’ senior notes schedule to mature in February 2021 and September 2021 and payments of $561 million to AXA primarily under a secured promissory note. These decreases to cash were partially offset by net proceeds of approximately $529 million and $370 million received from the minority IPO of Enact Holdings and the sale of Genworth Australia, respectively, and by net sales of investment securities in the current year. The decrease in equity securities was largely due to sales in the current year. |
• | DAC decreased $294 million principally attributable to DAC impairments and higher lapses in our life insurance business and shadow accounting adjustments associated with a decrease in unrealized gains in the current year. In connection with our periodic reviews of DAC for recoverability, we wrote off $76 million of DAC in our universal and term universal life insurance products in the current year due principally to lower future estimated gross profits. Shadow accounting adjustments decreased DAC by approximately $53 million, mostly in our term universal life insurance product, with an offsetting amount recorded in other comprehensive income (loss). |
• | Reinsurance recoverable decreased $148 million mainly attributable to the runoff of our structured settlement products ceded to Union Fidelity Life Insurance Company, an affiliate of our former parent, General Electric Company (“GE”). We also recorded $6 million of expected credit losses in the current year. |
• | Deferred tax asset increased $144 million largely due to a decrease in unrealized gains on derivatives and investments and from a deferred tax asset of $87 million recorded on the loss on sale of Genworth Australia, partially offset by the utilization of net operating losses and foreign tax credits in the current year. |
• | Separate account assets decreased $103 million primarily due to surrenders, partially offset by favorable equity market performance in the current year. |
• | Assets related to discontinued operations decreased $2,817 million due to the sale and deconsolidation of Genworth Australia in the current year. |
• | Future policy benefits decreased $901 million primarily driven by shadow accounting adjustments associated with a decrease in unrealized gains in the current year. The shadow accounting adjustments decreased future policy benefits by approximately $1,044 million, mostly in our long-term care insurance business, with an offsetting amount recorded in other comprehensive income (loss). The |
decrease was also attributable to reduced benefits of $679 million in the current year related to in-force actions approved and implemented, which included policyholder benefit reduction elections made as part of a legal settlement in our long-term care insurance business, net outflows driven by surrenders and benefits in our single premium immediate annuity products and from the runoff of our term life insurance products, including from higher lapses in the current year. These decreases were partially offset by aging of our long-term care insurance in-force block and higher incremental reserves of $495 million recorded in connection with an accrual for profits followed by losses in the current year. |
• | Policyholder account balances decreased $1,896 million largely attributable to shadow accounting adjustments associated with a decrease in unrealized gains in the current year. The shadow accounting adjustments decreased policyholder account balances by approximately $586 million, mostly in our universal life insurance products, with an offsetting amount recorded in other comprehensive income (loss). The decrease was also related to surrenders and benefits in our single premium deferred annuity products and from scheduled maturities of certain funding agreements in our universal life insurance and institutional products in the current year. |
• | Liability for policy and contract claims increased $257 million largely related to our long-term care insurance business primarily attributable to higher new claims as a result of the aging of the in-force block and a $61 million increase to claim reserves to account for changes to incidence and mortality experience driven by COVID-19, which we believe are temporary. The increase was also attributable to our Enact segment primarily driven by new delinquencies mostly associated with borrower forbearance resulting from COVID-19. These increases were partially offset by fewer pending claims in our life insurance business and higher claim terminations in our long-term care insurance business in the current year. |
• | Long-term borrowings decreased $991 million mainly attributable to the redemption of Genworth Holdings’ senior notes due in February 2021 and September 2021. |
• | Liabilities related to discontinued operations decreased $2,334 million predominantly from the sale and deconsolidation of Genworth Australia, which also resulted in a mandatory payment of approximately $247 million, including accrued interest, to AXA under the secured promissory note in the current year. In addition, during the third quarter of 2021, we repaid the remaining outstanding balance of the secured promissory note due to AXA, excluding future claims still in process, of approximately $296 million. |
• | We reported net income available to Genworth Financial, Inc.’s common stockholders of $741 million for the nine months ended September 30, 2021. |
• | Unrealized gains on investments and derivatives qualifying as hedges decreased $367 million and $220 million, respectively, primarily from an increase in interest rates in the current year. |
• | Additional paid-in capital decreased $158 million largely attributable to the IPO of 18.4% of Enact Holdings in September 2021. |
• | Noncontrolling interests increased $274 million related to the IPO of 18.4% of Enact Holdings in September 2021, partially offset by the deconsolidation of the ownership interest attributable to noncontrolling interests of Genworth Australia recorded in connection with the final disposition in March 2021. |
(Amounts in millions) |
2021 |
2020 |
||||||
Net cash from operating activities |
$ | 290 | $ | 1,452 | ||||
Net cash from (used by) investing activities |
469 | (1,279 | ) | |||||
Net cash used by financing activities |
(1,478 | ) | (734 | ) | ||||
|
|
|
|
|||||
Net decrease in cash before foreign exchange effect |
$ | (719 | ) | $ | (561 | ) | ||
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities available-for-sale, |
$ | — | $ | — | $ | 61,274 | $ | — | $ | 61,274 | ||||||||||
Equity securities, at fair value |
— | — | 156 | — | 156 | |||||||||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4) |
— | — | 6,916 | — | 6,916 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (30 | ) | — | (30 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Commercial mortgage loans, net |
— | — | 6,886 | — | 6,886 | |||||||||||||||
Policy loans |
— | — | 2,067 | — | 2,067 | |||||||||||||||
Other invested assets |
— | 52 | 2,283 | — | 2,335 | |||||||||||||||
Investments in subsidiaries |
15,283 | 15,624 | — | (30,907 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total investments |
15,283 | 15,676 | 72,666 | (30,907 | ) | 72,718 | ||||||||||||||
Cash, cash equivalents and restricted cash |
— | 588 | 1,349 | — | 1,937 | |||||||||||||||
Accrued investment income |
— | — | 626 | — | 626 | |||||||||||||||
Deferred acquisition costs |
— | — | 1,193 | — | 1,193 | |||||||||||||||
Intangible assets |
— | — | 147 | — | 147 | |||||||||||||||
Reinsurance recoverable |
— | — | 16,722 | — | 16,722 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (51 | ) | — | (51 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance recoverable, net |
— | — | 16,671 | — | 16,671 | |||||||||||||||
Other assets |
9 | 102 | 285 | — | 396 | |||||||||||||||
Intercompany notes receivable |
— | 55 | 1 | (56 | ) | — | ||||||||||||||
Deferred tax assets |
5 | 630 | (426 | ) | — | 209 | ||||||||||||||
Separate account assets |
— | — | 5,978 | — | 5,978 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
$ | 15,297 | $ | 17,051 | $ | 98,490 | $ | (30,963 | ) | $ | 99,875 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities and equity |
||||||||||||||||||||
Liabilities: |
||||||||||||||||||||
Future policy benefits |
$ | — | $ | — | $ | 41,794 | $ | — | $ | 41,794 | ||||||||||
Policyholder account balances |
— | — | 19,607 | — | 19,607 | |||||||||||||||
Liability for policy and contract claims |
— | — | 11,743 | — | 11,743 | |||||||||||||||
Unearned premiums |
— | — | 685 | — | 685 | |||||||||||||||
Other liabilities |
— | 72 | 1,496 | — | 1,568 | |||||||||||||||
Intercompany notes payable |
21 | 1 | 34 | (56 | ) | — | ||||||||||||||
Long-term borrowings |
— | 1,672 | 740 | — | 2,412 | |||||||||||||||
Separate account liabilities |
— | — | 5,978 | — | 5,978 | |||||||||||||||
Liabilities related to discontinued operations |
— | 32 | 4 | — | 36 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities |
21 | 1,777 | 82,081 | (56 | ) | 83,823 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Equity: |
||||||||||||||||||||
Common stock |
1 | — | 4 | (4 | ) | 1 | ||||||||||||||
Additional paid-in capital |
11,850 | 12,719 | 18,204 | (30,923 | ) | 11,850 | ||||||||||||||
Accumulated other comprehensive income (loss) |
3,800 | 3,800 | 3,844 | (7,644 | ) | 3,800 | ||||||||||||||
Retained earnings |
2,325 | (1,245 | ) | (6,719 | ) | 7,964 | 2,325 | |||||||||||||
Treasury stock, at cost |
(2,700 | ) | — | — | — | (2,700 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity |
15,276 | 15,274 | 15,333 | (30,607 | ) | 15,276 | ||||||||||||||
Noncontrolling interests |
— | — | 1,076 | (300 | ) | 776 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total equity |
15,276 | 15,274 | 16,409 | (30,907 | ) | 16,052 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities and equity |
$ | 15,297 | $ | 17,051 | $ | 98,490 | $ | (30,963 | ) | $ | 99,875 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities available-for-sale, |
$ | — | $ | — | $ | 63,495 | $ | — | $ | 63,495 | ||||||||||
Equity securities, at fair value |
— | — | 386 | — | 386 | |||||||||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4) |
— | — | 6,774 | — | 6,774 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (31 | ) | — | (31 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Commercial mortgage loans, net |
— | — | 6,743 | — | 6,743 | |||||||||||||||
Policy loans |
— | — | 1,978 | — | 1,978 | |||||||||||||||
Other invested assets |
— | 67 | 2,032 | — | 2,099 | |||||||||||||||
Investments in subsidiaries |
15,358 | 16,673 | — | (32,031 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total investments |
15,358 | 16,740 | 74,634 | (32,031 | ) | 74,701 | ||||||||||||||
Cash, cash equivalents and restricted cash |
— | 1,078 | 1,483 | — | 2,561 | |||||||||||||||
Accrued investment income |
— | — | 655 | — | 655 | |||||||||||||||
Deferred acquisition costs |
— | — | 1,487 | — | 1,487 | |||||||||||||||
Intangible assets |
— | — | 157 | — | 157 | |||||||||||||||
Reinsurance recoverable |
— | — | 16,864 | — | 16,864 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (45 | ) | — | (45 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance recoverable, net |
— | — | 16,819 | — | 16,819 | |||||||||||||||
Other assets |
2 | 146 | 256 | — | 404 | |||||||||||||||
Intercompany notes receivable |
— | 19 | — | (19 | ) | — | ||||||||||||||
Deferred tax assets |
13 | 767 | (715 | ) | — | 65 | ||||||||||||||
Separate account assets |
— | — | 6,081 | — | 6,081 | |||||||||||||||
Assets related to discontinued operations |
— | — | 2,817 | — | 2,817 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
$ | 15,373 | $ | 18,750 | $ | 103,674 | $ | (32,050 | ) | $ | 105,747 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities and equity |
||||||||||||||||||||
Liabilities: |
||||||||||||||||||||
Future policy benefits |
$ | — | $ | — | $ | 42,695 | $ | — | $ | 42,695 | ||||||||||
Policyholder account balances |
— | — | 21,503 | — | 21,503 | |||||||||||||||
Liability for policy and contract claims |
— | — | 11,486 | — | 11,486 | |||||||||||||||
Unearned premiums |
— | — | 775 | — | 775 | |||||||||||||||
Other liabilities |
55 | 156 | 1,403 | — | 1,614 | |||||||||||||||
Intercompany notes payable |
— | — | 19 | (19 | ) | — | ||||||||||||||
Long-term borrowings |
— | 2,665 | 738 | — | 3,403 | |||||||||||||||
Separate account liabilities |
— | — | 6,081 | — | 6,081 | |||||||||||||||
Liabilities related to discontinued operations |
— | 581 | 1,789 | — | 2,370 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities |
55 | 3,402 | 86,489 | (19 | ) | 89,927 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Equity: |
||||||||||||||||||||
Common stock |
1 | — | 3 | (3 | ) | 1 | ||||||||||||||
Additional paid-in capital |
12,008 | 12,890 | 18,562 | (31,452 | ) | 12,008 | ||||||||||||||
Accumulated other comprehensive income (loss) |
4,425 | 4,426 | 4,499 | (8,925 | ) | 4,425 | ||||||||||||||
Retained earnings |
1,584 | (1,968 | ) | (6,681 | ) | 8,649 | 1,584 | |||||||||||||
Treasury stock, at cost |
(2,700 | ) | — | — | — | (2,700 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity |
15,318 | 15,348 | 16,383 | (31,731 | ) | 15,318 | ||||||||||||||
Noncontrolling interests |
— | — | 802 | (300 | ) | 502 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total equity |
15,318 | 15,348 | 17,185 | (32,031 | ) | 15,820 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities and equity |
$ | 15,373 | $ | 18,750 | $ | 103,674 | $ | (32,050 | ) | $ | 105,747 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Revenues: |
||||||||||||||||||||
Premiums |
$ | — | $ | — | $ | 2,859 | $ | — | $ | 2,859 | ||||||||||
Net investment income |
(2 | ) | — | 2,506 | — | 2,504 | ||||||||||||||
Net investment gains (losses) |
— | — | 191 | — | 191 | |||||||||||||||
Policy fees and other income |
— | (1 | ) | 541 | 2 | 542 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues |
(2 | ) | (1 | ) | 6,097 | 2 | 6,096 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||||||
Benefits and other changes in policy reserves |
— | — | 3,522 | — | 3,522 | |||||||||||||||
Interest credited |
— | — | 381 | — | 381 | |||||||||||||||
Acquisition and operating expenses, net of deferrals |
20 | 10 | 839 | — | 869 | |||||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 269 | — | 269 | |||||||||||||||
Interest expense |
(1 | ) | 90 | 38 | 2 | 129 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
19 | 100 | 5,049 | 2 | 5,170 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries |
(21 | ) | (101 | ) | 1,048 | — | 926 | |||||||||||||
Provision (benefit) for income taxes |
(2 | ) | (21 | ) | 224 | — | 201 | |||||||||||||
Equity in income of subsidiaries |
760 | 829 | — | (1,589 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
741 | 749 | 824 | (1,589 | ) | 725 | ||||||||||||||
Income from discontinued operations, net of taxes |
— | 14 | 14 | — | 28 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
741 | 763 | 838 | (1,589 | ) | 753 | ||||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
— | — | 4 | — | 4 | |||||||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— | — | 8 | — | 8 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 741 | $ | 763 | $ | 826 | $ | (1,589 | ) | $ | 741 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Revenues: |
||||||||||||||||||||
Premiums |
$ | — | $ | — | $ | 3,836 | $ | — | $ | 3,836 | ||||||||||
Net investment income |
(3 | ) | 5 | 3,228 | (3 | ) | 3,227 | |||||||||||||
Net investment gains (losses) |
— | 6 | 486 | — | 492 | |||||||||||||||
Policy fees and other income |
— | 3 | 730 | (4 | ) | 729 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues |
(3 | ) | 14 | 8,280 | (7 | ) | 8,284 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||||||
Benefits and other changes in policy reserves |
— | — | 5,214 | — | 5,214 | |||||||||||||||
Interest credited |
— | — | 549 | — | 549 | |||||||||||||||
Acquisition and operating expenses, net of deferrals |
31 | 6 | 898 | — | 935 | |||||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 463 | — | 463 | |||||||||||||||
Interest expense |
1 | 175 | 26 | (7 | ) | 195 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
32 | 181 | 7,150 | (7 | ) | 7,356 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries |
(35 | ) | (167 | ) | 1,130 | — | 928 | |||||||||||||
Provision (benefit) for income taxes |
(2 | ) | (41 | ) | 273 | — | 230 | |||||||||||||
Equity in income of subsidiaries |
210 | 912 | — | (1,122 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
177 | 786 | 857 | (1,122 | ) | 698 | ||||||||||||||
Income (loss) from discontinued operations, net of taxes |
1 | (573 | ) | 86 | — | (486 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
178 | 213 | 943 | (1,122 | ) | 212 | ||||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
— | — | — | — | — | |||||||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— | — | 34 | — | 34 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 178 | $ | 213 | $ | 909 | $ | (1,122 | ) | $ | 178 | |||||||||
|
|
|
|
|
|
|
|
|
|
Parent |
All Other |
|||||||||||||||||||
(Amounts in millions) |
Guarantor |
Issuer |
Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Net income |
$ | 741 | $ | 763 | $ | 838 | $ | (1,589 | ) | $ | 753 | |||||||||
Other comprehensive income (loss), net of taxes: |
||||||||||||||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
(347 | ) | (348 | ) | (374 | ) | 696 | (373 | ) | |||||||||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
6 | 6 | 6 | (12 | ) | 6 | ||||||||||||||
Derivatives qualifying as hedges |
(220 | ) | (220 | ) | (250 | ) | 470 | (220 | ) | |||||||||||
Foreign currency translation and other adjustments |
(38 | ) | (38 | ) | 135 | 75 | 134 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other comprehensive income (loss) |
(599 | ) | (600 | ) | (483 | ) | 1,229 | (453 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive income |
142 | 163 | 355 | (360 | ) | 300 | ||||||||||||||
Less: comprehensive income attributable to noncontrolling interests |
— | — | 158 | — | 158 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders |
$ | 142 | $ | 163 | $ | 197 | $ | (360 | ) | $ | 142 | |||||||||
|
|
|
|
|
|
|
|
|
|
Parent |
All Other |
|||||||||||||||||||
(Amounts in millions) |
Guarantor |
Issuer |
Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Net income |
$ | 178 | $ | 213 | $ | 943 | $ | (1,122 | ) | $ | 212 | |||||||||
Other comprehensive income (loss), net of taxes: |
||||||||||||||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
764 | 765 | 765 | (1,530 | ) | 764 | ||||||||||||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
(6 | ) | (6 | ) | (6 | ) | 12 | (6 | ) | |||||||||||
Derivatives qualifying as hedges |
209 | 209 | 241 | (450 | ) | 209 | ||||||||||||||
Foreign currency translation and other adjustments |
25 | 25 | 55 | (50 | ) | 55 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other comprehensive income (loss) |
992 | 993 | 1,055 | (2,018 | ) | 1,022 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive income |
1,170 | 1,206 | 1,998 | (3,140 | ) | 1,234 | ||||||||||||||
Less: comprehensive income attributable to noncontrolling interests |
— | — | 64 | — | 64 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders |
$ | 1,170 | $ | 1,206 | $ | 1,934 | $ | (3,140 | ) | $ | 1,170 | |||||||||
|
|
|
|
|
|
|
|
|
|
Parent |
All Other |
|||||||||||||||||||
(Amounts in millions) |
Guarantor |
Issuer |
Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Cash flows from (used by) operating activities: |
||||||||||||||||||||
Net income |
$ | 741 | $ | 763 | $ | 838 | $ | (1,589 | ) | $ | 753 | |||||||||
Less income from discontinued operations, net of taxes |
— | (14 | ) | (14 | ) | — | (28 | ) | ||||||||||||
Adjustments to reconcile net income to net cash from (used by) operating activities: |
||||||||||||||||||||
Equity in income from subsidiaries |
(760 | ) | (829 | ) | — | 1,589 | — | |||||||||||||
Dividends from subsidiaries |
— | 370 | (370 | ) | — | — | ||||||||||||||
Amortization of fixed maturity securities discounts and premiums |
— | 3 | (141 | ) | — | (138 | ) | |||||||||||||
Net investment gains |
— | — | (191 | ) | — | (191 | ) | |||||||||||||
Charges assessed to policyholders |
— | — | (472 | ) | — | (472 | ) | |||||||||||||
Acquisition costs deferred |
— | — | (6 | ) | — | (6 | ) | |||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 269 | — | 269 | |||||||||||||||
Deferred income taxes |
— | 176 | 26 | — | 202 | |||||||||||||||
Derivative instruments, limited partnerships and other |
— | 74 | (326 | ) | — | (252 | ) | |||||||||||||
Stock-based compensation expense |
32 | — | — | — | 32 | |||||||||||||||
Change in certain assets and liabilities: |
||||||||||||||||||||
Accrued investment income and other assets |
(7 | ) | 13 | (123 | ) | — | (117 | ) | ||||||||||||
Insurance reserves |
— | — | 678 | — | 678 | |||||||||||||||
Current tax liabilities |
(6 | ) | 115 | (117 | ) | — | (8 | ) | ||||||||||||
Other liabilities, policy and contract claims and other policy-related balances |
(14 | ) | (55 | ) | 125 | — | 56 | |||||||||||||
Cash from (used by) operating activities—discontinued operations |
— | (561 | ) | 73 | — | (488 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) operating activities |
(14 | ) | 55 | 249 | — | 290 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from (used by) investing activities: |
||||||||||||||||||||
Proceeds from maturities and repayments of investments: |
||||||||||||||||||||
Fixed maturity securities |
— | — | 3,253 | — | 3,253 | |||||||||||||||
Commercial mortgage loans |
— | — | 601 | — | 601 | |||||||||||||||
Other invested assets |
— | — | 176 | — | 176 | |||||||||||||||
Proceeds from sales of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | 1,591 | — | 1,591 | |||||||||||||||
Purchases and originations of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | (4,181 | ) | — | (4,181 | ) | |||||||||||||
Commercial mortgage loans |
— | — | (743 | ) | — | (743 | ) | |||||||||||||
Other invested assets |
— | — | (447 | ) | — | (447 | ) | |||||||||||||
Short-term investments, net |
— | (25 | ) | 1 | — | (24 | ) | |||||||||||||
Policy loans, net |
— | — | 40 | — | 40 | |||||||||||||||
Intercompany notes receivable, net |
— | (36 | ) | (1 | ) | 37 | — | |||||||||||||
Capital contributions to subsidiaries |
(2 | ) | — | 2 | — | — | ||||||||||||||
Proceeds from sale of business, net of cash transferred |
— | — | 270 | — | 270 | |||||||||||||||
Cash used by investing activities—discontinued operations |
— | — | (67 | ) | — | (67 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) investing activities |
(2 | ) | (61 | ) | 495 | 37 | 469 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from (used by) financing activities: |
||||||||||||||||||||
Deposits to universal life and investment contracts |
— | — | 511 | — | 511 | |||||||||||||||
Withdrawals from universal life and investment contracts |
— | — | (1,582 | ) | — | (1,582 | ) | |||||||||||||
Repayment and repurchase of long-term debt |
— | (1,003 | ) | — | — | (1,003 | ) | |||||||||||||
Proceeds from sale of subsidiary shares to noncontrolling interests |
— | 529 | — | — | 529 | |||||||||||||||
Intercompany notes payable, net |
21 | 1 | 15 | (37 | ) | — | ||||||||||||||
Other, net |
(5 | ) | (11 | ) | 83 | — | 67 | |||||||||||||
Cash from financing activities—discontinued operations |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) financing activities |
16 | (484 | ) | (973 | ) | (37 | ) | (1,478 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $(1) related to discontinued operations) |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net change in cash, cash equivalents and restricted cash |
— | (490 | ) | (229 | ) | — | (719 | ) | ||||||||||||
Cash, cash equivalents and restricted cash at beginning of period |
— | 1,078 | 1,578 | — | 2,656 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash at end of period |
— | 588 | 1,349 | — | 1,937 | |||||||||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | — | $ | 588 | $ | 1,349 | $ | — | $ | 1,937 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Parent |
All Other |
|||||||||||||||||||
(Amounts in millions) |
Guarantor |
Issuer |
Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||
Net income |
$ | 178 | $ | 213 | $ | 943 | $ | (1,122 | ) | $ | 212 | |||||||||
Less (income) loss from discontinued operations, net of taxes |
(1 | ) | 573 | (86 | ) | — | 486 | |||||||||||||
Adjustments to reconcile net income to net cash from operating activities: |
||||||||||||||||||||
Equity in income from subsidiaries |
(210 | ) | (912 | ) | — | 1,122 | — | |||||||||||||
Dividends from subsidiaries |
— | 437 | (437 | ) | — | — | ||||||||||||||
Amortization of fixed maturity securities discounts and premiums |
— | 6 | (163 | ) | — | (157 | ) | |||||||||||||
Net investment (gains) losses |
— | (6 | ) | (486 | ) | — | (492 | ) | ||||||||||||
Charges assessed to policyholders |
— | — | (646 | ) | — | (646 | ) | |||||||||||||
Acquisition costs deferred |
— | — | (3 | ) | — | (3 | ) | |||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 463 | — | 463 | |||||||||||||||
Deferred income taxes |
(1 | ) | 212 | 17 | — | 228 | ||||||||||||||
Derivative instruments, limited partnerships and other |
— | (70 | ) | (42 | ) | — | (112 | ) | ||||||||||||
Stock-based compensation expense |
39 | — | — | — | 39 | |||||||||||||||
Change in certain assets and liabilities: |
||||||||||||||||||||
Accrued investment income and other assets |
2 | 16 | (105 | ) | (5 | ) | (92 | ) | ||||||||||||
Insurance reserves |
— | — | 1,217 | — | 1,217 | |||||||||||||||
Current tax liabilities |
(1 | ) | 41 | (34 | ) | — | 6 | |||||||||||||
Other liabilities, policy and contract claims and other policy-related balances |
11 | 30 | 784 | 5 | 830 | |||||||||||||||
Cash from (used by) operating activities—discontinued operations |
— | (258 | ) | 239 | — | (19 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from operating activities |
17 | 282 | 1,661 | — | 1,960 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from (used by) investing activities: |
||||||||||||||||||||
Proceeds from maturities and repayments of investments: |
||||||||||||||||||||
Fixed maturity securities |
— | — | 3,637 | — | 3,637 | |||||||||||||||
Commercial mortgage loans |
— | — | 744 | — | 744 | |||||||||||||||
Other invested assets |
— | — | 182 | — | 182 | |||||||||||||||
Proceeds from sales of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | 3,040 | — | 3,040 | |||||||||||||||
Purchases and originations of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | (7,763 | ) | — | (7,763 | ) | |||||||||||||
Commercial mortgage loans |
— | — | (547 | ) | — | (547 | ) | |||||||||||||
Other invested assets |
— | — | (449 | ) | — | (449 | ) | |||||||||||||
Short-term investments, net |
— | 45 | (10 | ) | — | 35 | ||||||||||||||
Policy loans, net |
— | — | 190 | — | 190 | |||||||||||||||
Intercompany notes receivable, net |
(10 | ) | (16 | ) | 200 | (174 | ) | — | ||||||||||||
Capital contributions to subsidiaries |
(2 | ) | — | 2 | — | — | ||||||||||||||
Cash used by investing activities—discontinued operations |
— | — | (222 | ) | — | (222 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) investing activities |
(12 | ) | 29 | (996 | ) | (174 | ) | (1,153 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows used by financing activities: |
||||||||||||||||||||
Deposits to universal life and investment contracts |
— | — | 862 | — | 862 | |||||||||||||||
Withdrawals from universal life and investment contracts |
— | — | (2,282 | ) | — | (2,282 | ) | |||||||||||||
Redemption of non-recourse funding obligations |
— | — | (315 | ) | — | (315 | ) | |||||||||||||
Proceeds from the issuance of long-term debt |
— | — | 738 | — | 738 | |||||||||||||||
Repayment and repurchase of long-term debt |
— | (490 | ) | — | — | (490 | ) | |||||||||||||
Intercompany notes payable, net |
— | (190 | ) | 16 | 174 | — | ||||||||||||||
Other, net |
(5 | ) | (14 | ) | 17 | — | (2 | ) | ||||||||||||
Cash used by financing activities—discontinued operations |
— | — | (18 | ) | — | (18 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash used by financing activities |
(5 | ) | (694 | ) | (982 | ) | 174 | (1,507 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $18 related to discontinued operations) |
— | — | 15 | — | 15 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net change in cash, cash equivalents and restricted cash |
— | (383 | ) | (302 | ) | — | (685 | ) | ||||||||||||
Cash, cash equivalents and restricted cash at beginning of period |
— | 1,461 | 1,880 | — | 3,341 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash at end of period |
— | 1,078 | 1,578 | — | 2,656 | |||||||||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
— | — | 95 | — | 95 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | — | $ | 1,078 | $ | 1,483 | $ | — | $ | 2,561 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors |
Number |
Description | |
31.1 | Certification of Thomas J. McInerney (filed herewith) | |
31.2 | Certification of Daniel J. Sheehan IV (filed herewith) | |
32.1 | Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code—Thomas J. McInerney (filed herewith) | |
32.2 | Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code—Daniel J. Sheehan IV (filed herewith) | |
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extension Schema Document | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101) |
GENWORTH FINANCIAL, INC. (Registrant) | ||||||
Date: November 4, 2021 |
||||||
By: |
/s/ Matthew D. Farney | |||||
Matthew D. Farney Vice President and Controller (Principal Accounting Officer) |